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ABSTRACT 
 
Yoakum, Ryan J. Ph.D., Biomedical Sciences Program, Wright State University, 
2015. Modification Reactivity Analysis of human Replication Protein A in Biologically 
Important States 
 
 
Human Replication Protein A (RPA) is a heterotrimeric protein consisting of 70, 
32, and 14 kDa subunits. RPA is the predominant single stranded DNA binding protein 
within the cell. It is involved in all forms of the DNA metabolic pathways, including but 
not limited to, replication, recombination, damage repair, as well as cell cycle and DNA 
check point signaling. RPA is phosphorylated (pRPA) during G1-S phase and is 
dephosphorylated during M phase. Further, RPA is hyperphosphorylated during DNA 
damage.  
Through the use of x-ray crystallography and nuclear magnetic resonance, 
researchers have proposed models and structures based on truncated portions of the 
protein. Currently, there are no x-ray crystallographic or NMR models for the full RPA 
heterotrimer. Our lab, using chemical modification reactivity analysis data (MRAN) and 
simulated annealing, has a proposed model for the complete structure of native RPA 
unbound to ssDNA. 
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To further refine models for the complete structure of RPA, we have used a 
series of experiments in which the structure of RPA was probed via Chemical 
Modification Reactivity Analysis (MRAN). Specifically, lysines within RPA were probed by 
sulfo-NHS-acetate and aspartates and glutamates were probed with N-(3-
dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride (EDC) chemical reagents 
under conditions in which RPA was in native, phoshphorylated, single strand DNA 
(ssDNA) bound, and phosphorylated ssDNA bound states to determine the structural 
changes that result from different binding and phosphorylation states. Chemical 
modification and exhaustive proteolysis were used in conjunction with MALDI-TOF mass 
spectrometry to determine local and global structural changes that occur within the 
protein under each specific reaction condition.  
Through the use of photochemical crosslinks between RPA and dT30 ssDNA, the 
sites and specific amino acids involved in binding between RPA and ssDNA were 
mapped. All DNA binding domains (DBDs) of the heterotrimer were shown to interact 
with the ssDNA including the 14 kDa subunit (DBD E). The interaction between DBDs A, 
B, C, D, and F coincided with reports of the interaction between RPA and ssDNA. Our 
data for the interaction between DBD E of the 14 kDa subunit and ssDNA provides a 
strong argument that the 14kDa subunit is involved in at least one mechanism of ssDNA 
binding within the cell. MRAN data further suggests that the modular rearrangement of 
RPA is necessary, and that RPA goes from a compact conformation with DBDs A & B 
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docked to the trimerization core in the ligand-free state to an extended conformation in 
which DBDs A & B are extended by a tethered region away from the trimerization core 
of RPA when bound to ssDNA.  
Further, the structural analysis of RPA and pRPA through chemical modification 
reactivity analyses in both apo and ssDNA bound states provides greater detail of the 
local conformational changes that the heterotrimer undergoes between these states. 
This data suggests that RPA and pRPA are similar and that the molecule undergoes 
specific local changes due to changes in electrostatic and hydrophobic potential of 
specific amino acids within each domain. It further demonstrates that the local changes 
in surface accessibility do not affect global structure of the domains, or of the molecule 
as a whole, but rather represents minor changes that influence specific amino acid-
ligand interactions. The data suggest that RPA and pRPA undergo a significant 
rearrangement when bound to ssDNA. The dissociation of DBDs A & B from the 
trimerization core represents a significant change in structure from the ssDNA free 
state. Evaluation of these changes in relation to proposed structures for RPA allows for 
targeted adjustments to the proposed models to better fit experimental data and gives 
a more accurate representation of the structure in solution under each reaction 
condition.  
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1. OVERVIEW OF HUMAN REPLICATION PROTEIN A and MODIFICATION 
REACTIVITY ANALYSIS 
Replication protein A (RPA) is a single stranded DNA binding protein (SSB) and 
was originally purified from human cell extracts as a component essential for simian 
virus 40 (SV40) DNA replication in vitro1. RPA binds with high affinity to single strand 
DNA (ssDNA) and with much lower affinity to double strand DNA (dsDNA) and RNA2. 
Although several eukaryotic SSB’s have been identified previously from both viruses and 
cells, RPA was the first cellular SSB that was shown to be directly involved in DNA 
metabolism3. RPA is in high abundance in human cells and appears to be the most 
abundant SSB4. There are estimated to be between 3x10 4–5 and 2 x 105 molecules of 
RPA per cell in transformed human cells5. 
 RPA is a hetero-trimeric protein consisting of 70, 32, and 14 kDa subunits5 
(Figure 1). It is involved in, but not limited to: replication, recombination, damage repair, 
as well as cell cycle and DNA check point signaling6. RPA has multiple binding partners, 
and serves the role of a recognition factor6. Crystal structures for individual subunits or 
truncated and modified segments of RPA have been reported7, but as yet, no 
crystallographic or NMR-based three-dimensional structural image of the complete 
holoenzyme or the apoenzyme8 has been reported. Using a variety of experimental 
methods, 6 oligonucleotide/oligosaccharide binding regions (OB) or DNA Binding 
Domain (DBD) structures have been proposed for RPA. The DBDs are labeled A-F, and  
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Figure 1. Schematic representation of the 3 subunits of RPA.   
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consist of 5  strands in a Greek-key  barrel9. The 70 kDa subunit contains DNA binding 
domains F, A, B, and C (Figure 1) as well as non-structured regions within the N terminus 
(Figure 2)10. The 32 kDa subunit contains DBD D and the 14 kDa subunit contains DBD E 
(Figure 1)10. Not all DBDs have been assigned a DNA binding function. 
No disorders are associated with the genes that code for the subunits of RPA, 
however, mutations and or deletions in genes and gene products known to interact with 
RPA have been associated with breast, colon, and lymphoid cancers11,12,13. In mouse 
models homozygotic deletion of RPA leads to embryonic lethality where as 
heterozygotic deletion leads to tumorogenesis14. 
Traditionally, to resolve protein structure, scientists have turned to x-ray 
crystallography and nuclear magnetic resonance spectroscopy15 (NMR).  While both x-
ray crystallography and NMR are standards for resolving structural detail of proteins, 
neither experimental approach is appropriate in understanding protein structure under 
all physiological conditions. The dehydrated and closely packed crystal environment is 
frequently high in salinity. This not only changes hydrophobic interaction, but also 
changes electrostatic potential from physiological solution, and thus potentially changes 
protein folding and amino acid interaction relative to the solution state. Further, 
proteins are flexible, and contain highly disordered regions that may be resistant to 
crystallization. This can make x-ray crystallization a poor choice for some proteins16,17,18. 
NMR spectroscopy is limited by the size of the protein being studied. Many proteins fall  
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Figure 2.  Ribbon model of M80PS Human Replication Protein A with subunits colored as 
follows. The N terminus of the 70 kDa subunit (DBD F) painted brown, DBD A painted 
raspberry, DBD B painted ruby, and DBD C painted salmon. The N terminus 32 kDa 
subunit painted cyan, DBD D painted sky blue, and the C terminus painted blue. The 14 
kDa subunit painted yellow. Unstructured regions were painted white.  
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outside of the size range readily approachable by NMR, making this technique 
impractical for some proteins as well17,19 ,20. 
 Another approach for resolving protein structure is computer modeling. While 
current computational methods can provide rapid protein structure prediction, they can 
be highly inaccurate21. When comparing modern predictive software with known crystal 
structures, current software is able to accurately predict the structure of proteins less 
than 50% of the time20. To resolve the limitations of x-ray crystallography, NMR 
spectroscopy, and computer modeling, modification chemical reactivity analysis (MRAN) 
was developed.  
MRAN works on the principle that a protein’s three-dimensional structure is 
reflected in an interpretable way by the reactivity of amino acids within that protein. 
Targeted amino acids are analyzed by specific chemical probes to assess their chemical 
reactivity based on selected physical characteristics of the microenvironment of those 
residues8. These reactions reflect surface accessibility, electrostatic interactions, nearest 
neighbor constraints as well as the chemical nature of the targeted residues22.  
Determining which amino acids are affected by chemical modifiers describes shifts in 
protein structure under varying conditions23. In essence, reactivity can indicate 
conformation, and additionally, conformation can change.  
Despite the complexity of protein structure, only a small number of protein 
functional groups comprise selectable targets for practical modification methods22. In 
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fact, just four protein functional groups are chemical targets for the vast majority of 
crosslinking and chemical modification approaches. These functional groups consist of 
primary amines, carboxyls, sulfhydryls, and carbonyls22. In principle, amino acids that 
are surface-exposed are reactive with appropriate chemicals in solution23,24. Those that 
are partially buried are fractionally reactive 24. Buried residues that have no solvent 
accessibility are nonreactive. Tertiary structure of the protein dictates the reactivity of 
its residues, and thus chemical reactions with amino acid functional groups reveals 
structural information about the protein. Mass spectra obtained from samples treated 
with covalent chemical modifiers, like acetylation and carboxy-methylation that target 
amino acid functional groups, provide information on the environment of residues 
within a protein, but there is still a significant gap in the field of protein modeling and its 
real world application25.  
Another approach that attempts to discern protein structure is predictive 
modeling. Predictive modeling by computational methods produces a large selection of 
structures that fit the criteria interposed by the software. Selecting which structure best 
represents the protein in solution is aided by experimental data, like that provided by 
MRAN. This approach provides new and greater detail in understanding the protein’s 
structure and additionally allows probing of the structure in the presence of differing 
conditions such as in the presence of ligand or substrate. Adapting MRAN data to 
predictive modeling gives direct experimental observations that can be used to correlate 
 
9 
 
data from in vitro experiments with a predicted or reported structure, and 
simultaneously rules out structures that conflict with observed reactivity data. Using this 
analysis for a particular protein not only provides an insightful approach to tackling the 
problem of determining a protein’s structure, but enhances the software, 
crystallographic, and NMR based approaches to predictive modeling. These methods 
were employed in studies reported here. 
As RPA is a large and highly flexible protein that binds to ssDNA, it presents 
unique challenges when assessing its structure in the presence or absence of ssDNA 
ligand. To address this issue, photo-chemical covalent crosslinking is employed. Many 
protein–nucleic acid complexes have been studied by photochemical crosslinking26. UV-
induced crosslinking of protein to nucleic acids allows the structural analysis of the 
conjugated protein to be to a specific amino acid residue in a portion of the nucleic acid 
binding site. Additionally, covalent crosslinks between the protein and ssDNA assures 
that the crosslinked protein retains the ssDNA, and any conformation unique to it when 
probed by additional means. Mass spectrometry can be used to identify purified 
peptide–nucleic acid heteroconjugates and place the amino acid in the protein’s primary 
structure. The use of UV irradiation to photo crosslink ssDNA to RPA was deployed in 
studies reported here to determine specific regions of the protein that are bound to the 
DNA under a variety of experimental conditions27. This allowed direct determination of 
the sites of interaction between RPA and single strand DNA. The UV-B induced 
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photocrosslinking reaction created a covalent bond between thymidines in a 5’6FAM 
Poly T 30mer with lysines, tyrosines, and tryptophans in the protein (Figure 3). 
Covalently crosslinking the ssDNA ligand to RPA, and its subsequent mass spectral 
analysis provided direct evidence for all ssDNA interacting domains of the protein. More 
specifically, the regions of each subunit of RPA that directly bind with ssDNA in native 
and phosphorylated states were determined. 
Matrix assisted laser deabsorbtion/ionization time of flight mass spectroscopy 
(MALDI-TOF) is a frequently used technique for characterizing peptide fragments 
generated during in vitro analysis of proteins28. It provides a very sensitive method for 
identifying specific peptides in complex sample sets. Monitoring changes in the mass of 
peptides by mass spectroscopy analysis allows all peptides generated through the 
experimental protocols to be examined and specific locations of modifications to be 
efficiently identified. One key element of this analysis is the identification of specific 
peptides and amino acids that are modified by the chemical probing agents, 
phosphorylated amino acids, as well as covalently crosslinked segments of protein with 
ssDNA.  
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Figure 3. Adducts arising from the photoreactions of thymine with cysteine (left), N-
acetyltyrosine (right) and the reaction of thymidine with lysine (bottom).  
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RPA Domain and Subunit Structural Information 
RPA 70 
Binding interactions involving the 70 kDa subunit have been implicated in many 
critical activities within the cell. The 70 Kda subunit contains DBDs A & B, which 
combined, make the highest affinity reactive sites for ssDNA binding within the protein. 
This subunit is essential for DNA replication, repair, and recombination29. The N 
terminus of the 70 kDa subunit interacts with a multitude of proteins partners. 
Interactions between SV40T antigen30, GAL431, VP1632, and p5333 have been mapped to 
both the N-terminal domain (residues 1-110) and to the A & B DBDs (residues 170-450). 
The N-terminus of the 70 kDa subunit is the region of the 70 kDa subunit associated 
with the stimulation of DNA polymerase alpha/primase34. The 70 kDa subunit also binds 
with DNA helicases and stimulates the unwinding of hundreds to thousands of 
nucleotides35. Proximal to the 70 N-terminal region and connected by a linker region are 
DNA binding domains, A & B36. DBD A has the highest affinity for ssDNA2. DBD B is 
connected to DBD A by a short linker region and together with DBD A, is associated with 
the small DNA substrate binding mode of RPA37. DBDs A & B can bind to a 8 nt single 
strand ligand, the minimum length ligand necessary for DNA binding38 with the entire 
protein. Deletion mutants of RPA which lack the A and B domain are replication 
deficient and cause cell death39. On the C terminus of the 70 kDa subunit and connected 
to DBD B again by an unstructured linker region is another DNA binding domain, DBD 
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C40. DBD C has lower affinity for ssDNA than A or B, and also is thought to serve a 
structural role for formation of the hetero-trimeric RPA complex40 by interacting with 
the 14 and 32 kDa subunits. The C-terminal domain contains a putative zinc-finger motif 
near residue 500. This zinc-finger is conserved in all RPA homologues41.   
RPA 32   
As with the 70 kDa subunit, the 32 kDa subunit is essential for RPA function42.  
The N terminus of the 32 kDa subunit is phosphorylated in a cell cycle dependent 
manner, with deletion analysis showing that the N-terminal 35 amino acids are essential 
for phosphorylation6. The phosphorylated amino acids in the N terminus of the 32 kDa 
subunit are proposed to be in an exposed/extended conformation that changes after 
RPA binds to single strand DNA43. Deletion of the N-terminus of the 32 kDa subunit does 
not affect ssDNA binding affinity, RPA complex formation, or the ability of RPA to 
stimulate DNA polymerase activity and support DNA replication in vitro6. The N-
terminus of the 32 kDa subunit has also been shown to be involved in protein-protein 
interactions43. More specifically, XPA, RAD51, and uracil-DNA glycosylase have direct 
interaction with the N-terminus of the 32 kDa subunit44,45.  The 32 kDa subunit also 
contains DBD D, a low affinity DNA binding site, and a winged helix motif at its C 
terminus10. 
RPA 14 
The 14 kDa subunit is essential for RPA function. While the 14 kDa subunit has an 
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OB fold, DBD E, it is believed that this subunit serves a structural role necessary for 
proper formation of the heterotrimer10. EMSA analysis has shown that the 14 kDa 
subunit binds to ssDNA. However, no structural models presented to date support this 
evidence46. 
Phosphorylation 
An important aspect of RPA’s structure and function is its phosphorylation state. 
Researchers report a large number of potential phosphorylation sites in RPA47, 48. 
Phosphorylation of RPA occurs in a cell cycle dependent manner and in response to DNA 
damage49. This phosphorylation of RPA occurs at multiple serine and threonine 
residues50. The N terminus of RPA’s 32 kDa subunit is essential for its phosphorylation51 
and requires that ssDNA be bound to RPA52. The stimulation of phosphorylation in the 
presence of ssDNA is thought to be caused by a DNA induced change in conformation of 
the 32 kDa subunit, which presents a more favorable surface for phosphorylation49. RPA 
is phosphorylated during G1-S phase and is dephosphorylated during M phase50. 
Replication Protein A is hyperphosphorylated during DNA damage48.  RPA is 
phosphorylated by multiple kinases, including the cyclin-dependent kinase family (Cdk, 
also known as the p34cdc2 kinase family)50, the DNA-dependent protein kinase (DNA-
PK)50, and the ATM-ATR family of kinases53, as well as several uncharacterized kinases. 
DNA-unwinding activity in the presence of RPA is stimulated after phosphorylation by 
p34cdc2 kinase54. While Cdk family kinases activate G1 extracts for replication and RPA 
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phosphorylation, they are responsible for little if any direct phosphorylation of RPA55. 
Primarily, phosphorylation of RPA is through DNA-dependent protein kinase (DNA-PK)49. 
DNA-PK is a serine/threonine kinase that is activated by dsDNA56. DNA-PK is involved in 
both recombination and DNA repair56. Cells with decreased DNA-PK activity have 
defects in RPA phosphorylation33. Phosphorylation of RPA inhibits its interaction with 
replication centers. The phosphorylation of RPA directly affects its structure and more 
specifically its function within the cell47.  Understanding changes to the structure of RPA 
caused by its phosphorylation state provides greater insight into the rearrangement of 
the protein as it performs different functions within the cell.  
ssDNA Binding 
RPA binds tightly to ssDNA as a heterotrimeric complex57 with an apparent 
association constant of 1x109–1011 M−1, 2,58, . The affinity of RPA for both dsDNA and RNA 
is at least three orders of magnitude lower than it is for ssDNA2 with the hierarchy of 
RPA binding to nucleic acids in order of decreasing affinity as follows: ss-polypyrimidines 
> ssDNA with mixed sequence > ss-polypurines > RNA > dsDNA39. RPA shows a distinct 
preference for binding polypyrimidine sequences over polypurine sequences with a 50-
fold higher preference for pyrimidines31. Analysis of binding to oligonucleotides of 
varying length showed that RPA has a strong length dependence for binding1. The 
affinity of RPA for oligodeoxythymidine of 30 residues in length (dT30) was high (Kd 
1x109 M−1)59, but as length decreases the affinity constant decreases by almost two 
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orders of magnitude (dT15, Kd 1x109 M−1; dT12, Kd  2 x 108 M−1; and dT10, Kd 7 x 107 
M−1)59. The length of the occluded binding site for RPA has been defined as 30 
nucleotides (nt) in length and the cooperativity of RPA binding has been shown to be 
very low30. However, RPA is still 10–20 times more likely to bind adjacent to an already 
bound molecule of RPA3.  RPA undergoes a conformational change when it binds to 
ssDNA60. This change has been demonstrated by microscopic visualization of RPA 
complexes and by changes in proteolytic sensitivity60. This conformational change 
involves both the 70 kDa subunit and the 32 kDa subunit61. When accounting for the 
contour length of ssDNA coated with RPA, it appears that DNA does not wrap around 
RPA. More so, deletion analysis has identified the central region of the 70 kDa subunit of 
RPA, (residues 170-450) DBDs A & B, as the region necessary for high-affinity ssDNA-
binding31. 
  
 
18 
 
 
Hypothesis and Specific Aims 
Hypothesis: 
RPA undergoes a structural rearrangement when phosphorylated. Additionally, RPA 
undergoes structural changes when bound to ssDNA. The structure undergoes further 
changes between the phosphorylated and phosphorylate ssDNA bound states.  
Specific Aims: 
1) Determine all interaction sites associated with ssDNA binding in native and 
phosphorylated RPA.  
2) Identify structural changes associated with DNA binding and phosphorylation of 
Human Replication Protein A.  
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2. Rationale 
Introduction 
RPA Purification 
Using an expression system, Escherichia coli with recombinant RPA, we were 
able to express and purify milligram quantities of RPA. The standard protocol used 
Cibacron Blue affinity chromatography in conjunction with hydroxylapatite and Q 
sepharose columns5 (Figure 4). It is with the highly purified protein product that all 
subsequent assays were conducted.  
RPA adducts 
Understanding any structural changes that occur within RPA when in it is in its 
phosphorylated state was one of the primary goals of our research. To achieve this, in 
vitro hyperphosphorylated RPA was produced and purified by incubating purified RPA 
extracted from Escherichia coli with HeLa cell extracts to induce the DNA damage 
phosphorylation pathways48. Further, identifying sites of ssDNA binding as well as 
structural differences between RPA and pRPA were also of interest. To produce and 
purify RPA or pRPA ssDNA heteroconjugates, these proteins were preincubated with a 
single strand poly dT30mer containing a 5’ 6FAM fluorophore (Figure 6), and subjected 
to UV-B light to achieve photo crosslinking (Figure 3).  
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Figure 4. Purification Scheme of the p11d-tRPA Plasmid for the Purification of Human 
Replication Protein A. 
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RPA and pRPA chemical modifications 
Structural characteristics of 4 different reactive states of RPA, pRPA, ssDNA:RPA, 
and ssDNA:pRPA were investigated by modification reactivity analyses. RPA, pRPA, 
ssDNA:RPA, and ssDNA:pRPA were incubated with either sulfo-NHS-acetate, or EDC and 
glycine methyl ester (Figure 5). The sulfo-NHS-acetate reaction targeted lysines within 
the protein and produced an acetylated lysine adduct for all surface exposed lysines 
involved in the reaction. EDC and glycine methyl ester targeted the carboxylic acids, 
aspartate and glutamate, forming an acyl glycine ester on all surface exposed carboxylic 
acids in the protein62.  
SDS PAGE and In-Gel Exhaustive Digestion 
SDS PAGE was used to visualize purified fractions of RPA, separate reacted 
protein products from reaction mixtures, report phosphorylation of RPA, as well as 
verify photo crosslinking of ssDNA with RPA. To ensure that preparations contained full 
length RPA, pRPA, ssDNA:RPA and ssDNA:pRPA, bands assigned to the 70, 32, and 14 
kDa subunits for RPA and pRPA as well as, bands assigned to ssDNA:RPA and 
ssDNA:pRPA covalent heterconjugates were excised from the gel and subjected to 
exhaustive in-gel digestion. This provided homogenous samples for each subunit or 
heteroconjugate and eliminated the potential of introducing truncated species in 
samples submitted for mass spectral analysis. Covalently crosslinked protein:dna  
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Figure 5. Reagents used to covalently label Replication Protein A. The top panel shows 
the acetylating reagent N-hydroxysulfosuccinimidyl acetate (sulfo-nhs acetate). The 
bottom panel shows N-(3-Dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride 
(ECD).
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heteroconjugates were found to be resistant to proteolysis, therefore, Micrococcal 
nuclease was first used to exhaustively digest the crosslinked ssDNA substrate bound to 
RPA63. For each reaction condition, samples were digested with trypsin for 1 set of mass 
spectral analyses. Separate gels were digested with chymotrypsin using the same 
experimental conditions for a second set of mass spectral analyses. The experimental 
scheme utilized the differing weights and physical properties resulting from the 
separate proteolytic digestions to improve total sequence coverage for the protein and 
subunits investigated by mass spectral analysis. Through this scheme we were able to 
improve sequence coverage to 80% for all 3 subunits of RPA. Sequence coverage of 
amino acids in the interaction sites of each subunit was 97.7%, 86.0%, 88.4%, and 82.6% 
for RPA, ssDNA:RPA, pRPA, ssDNA:pRPA, respectively (data not shown).  
Mass Spectrometry of RPA, pRPA, ssDNA:RPA and ssDNA:pRPA 
Monitoring changes in the mass of peptides by mass spectroscopic analysis 
provides a very sensitive method for identifying specific peptides in complex sample sets 
and allows all peptides generated through the experimental protocols reported here to 
be examined. Specific locations of peptides and amino acids that are phosphorylated, 
modified by the chemical probing agents, as well as covalently crosslinked with ssDNA 
can be efficiently identified. MMass mass spectrometry software (MMass.org) was used 
to compare recorded spectra to predicted theoretical spectra of the covalently modified 
proteins. Peaks were assessed for fit to predicted spectra to determine the presence of 
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peaks assigned as products of the 70, 32, and 14 kDa subunits of RPA. 
Materials and Methods 
Chemicals 
HEPES, Myo-Inositol, DTT, EDTA, NaSCN, KCL, KPO4, ZnCl, and Sulfo NHS Acetate, 
Glycine methyl ester, and N-(3-Dimethylaminopropyl)-N′-ethylcarbodiimide 
hydrochloride (ECD) were purchased from Sigma (St. Louis, MO). Hydroxylapatite was 
purchased from TOSOH Bioscience (Grove City, OH). Protein grade IPTG and sequence 
grade Trypsin and Chymotrypsin were purchased from Gold Biotechnology (St. Louis, 
MO). Protease-phosphatase mini tablets and a protease inhibitor cocktail containing 
Leupeptin, PMSF and Pepstatin A, as well as the Pageruler plus protein ladder were 
purchased from Pierce (Rockford, IL). Bio-Rad protein assay kits were purchased from 
Bio-Rad (Hercules, CA). A peptide standard for mass spectral calibration was purchased 
from Bruker Daltonics (Billrica, MA). Mass Spectral Grade CHCA was purchased from 
Fisher Scientific (Waltham, MA). Pro Q Diamond gel stains were purchased from Life 
Technologies (Carlsbad, CA). Micrococcal nuclease was purchased from Worthington 
Biochemical (Lakewood, NJ). A 5’6FAM dt30 was purchased from IDT (Coralville, IA) 
(Figure 6). 
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Figure 6. Structure of Fluoroscein attached to the 5’ end of the poly dT 30mer.  
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Buffers 
HI Buffer (30 mM HEPES p.H. 7.8, 0.25 % myo-inositol, 1 mM DTT, 0.25 mM EDTA, and 
30 mM ZnCl) was used in experiments that were conducted on native RPA. For 
purification experiments, HI buffer was modified as needed for each individual step. 
Chromatographic columns were preloaded with HI buffer containing 1μM Leupeptin, 1 
mM Pepstatin A, and 10 mM PMSF. Solutions containing, 80 mM KCl, 0.8 M KCl, 0.5 M 
NaSCN, and 1.5 M NaSCN, were used for wash and elution steps involving a Cibacron 
Blue column. Solutions containing 30 mM KCl, 80 mM KPO4, and 0.5 M KPO4 were used 
for wash and elution involving the hydroxylapatite column, and solutions containing 50 
mM KCL, 100 mM KCl, 200, mM KCl, and 400 mM KCl were used for wash and elution 
steps involving the mono Q anion exchange column. 
RPA Purification 
Plasmid p11d-tRPA (Figure 7) which, contains DNA corresponding to all RPA subunits, 
was obtained as a generous gift from Dr. Marc Wold (Department of Biochemistry, 
University of Iowa College of Medicine). It is used to transform cells of the chemically 
competent BL21 (DE3) strain of Escherichia coli. To accomplish this, 10 μl of plasmid 
DNA solvated in Milipore H2O was mixed with 50 μl of chemically competent BL 21 cells, 
and heated in a water bath to 42o C for 1 min. The DNA and competent cells were then 
placed on ice for 5 min. The cells were then used to inoculate 80 ml of autoclaved LB 
media and incubated at 37o C for 1 hr with shaking. 50 ml of cells were used to inoculate  
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Figure 7. Plasmid p11d-tRPA used for the purification of Human Replication Protein A.  
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Chloramphenicol and Ampicilin treated plates that were grown overnight at 37o C. A 
single colony was used to inoculate 1L of autoclaved LB Media and allowed to incubate 
overnight at 37o C without shaking. The inoculated media was then combined with 
another liter of autoclaved LB media and placed into a Microferm fermentor (New 
Brunswick Inc., Edison, NJ) reaction vessel with air settings of 3L/min (air at 70o C and 
14.7 PSIA) and continual agitation. Cell growth was monitored by UV/Vis 
spectrophotometry at 600 nM. When cells were in log phase growth (600 nM measuring 
0.60) the transformed cells were then induced with 1 mM IPTG to express human 
recombinant RPA. Cells were collected after 3hrs of induction, centrifuged at 4,000 rpm 
in a Beckman Coulter (Beckman Coulter Inc., Hebron, KY) centrifuge with a JA-10 rotor 
and pellets were collected. Cell pellets were solvated in 25 ml of HI buffer containing 
protease inhibitors and lysed at 14,000 psi using an Emusliflex (Avestin Inc., Ottawa, 
Canada). Cell lysate was centrifuged at 14,000 rpm in a JA-14 rotor in a Beckman Coulter 
centrifuge (Beckman Coulter Inc., Hebron, KY) and collected. The purification is a slight 
modification of a previously described procedure5 (Figure 4). To ensure zinc was 
maintained in the protein, it was placed in higher concentration than EDTA for all 
buffers5. Samples collected from the final chromatographic step of the purification were 
electrophoresed on 12% SDS acrylamide gels and stained with coomassie blue to verify 
purity (Figure 8). 
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Figure 8. SDS Polyacrylamide gel stained with coomassie blue showing the final purified 
product of Human Replication Protein A.  Lane 1 is the MW ladder, lane 2 is a fraction of 
purified hRPA, lane 3 is a fraction of purified hRPA, and lane 4 is a fraction of purified 
hRPA. 
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Phosphorylation of RPA 
In vitro hyperphosphorylated RPA was prepared by incubating purified RPA extracted 
from Escherichia coli with HeLa cell extracts supplemented with a Pierce protease 
inhibitor cocktail containing sodium fluoride, sodium orthovanadate, sodium 
pyrophosphate and beta-glycerophosphate. Prior to extraction, the HeLa cells were 
treated with aphidoclin and hydroxyl-urea, to promote DNA damage and induce the 
DNA damage phosphorylation pathways48. The kinases within the HeLa cell extracts 
were used to phosphorylate RPA, and the resulting phosphorylated RPA was re-purified 
using the same procedure as used to purify RPA5. Samples collected from the final 
chromatographic step of the repurification were electrophoresed on 12% SDS 
acrylamide gels and stained with coomassie blue to verify purity (Figure 9). 
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Figure 9. SDS polyacrylamide gel stained with coomassie blue showing the final purified 
product of phosphorylated human Replication Protein A. Lane 1 is the MW ladder. Lane 
2 is the final purified fraction of pRPA.  
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UV Crosslinking 
To achieve covalent crosslinking, purified RPA or pRPA heterotrimers were preincubated 
with a single strand poly dT30mer containing a 5’ 6FAM fluorophore using a Stratalinker 
UV crosslinker (Stratagene California, La Jolla, CA). A stoichiometric ratio of 1μg RPA: 
1μg DNA was placed into solution. 40 μl of RPA in HI buffer was mixed with 40 μl 5’ 6 
FAM dT30mer in a 96 well flat bottom plate. The samples were then exposed to UV-B at 
254 nm for the duration necessary to deliver a dose of 5000 μJoules. This dose was 
determined by systematically increasing crosslinking UV dose and selecting the optimal 
dose for crosslinking (Figure 10).  
RPA and pRPA chemical modifications 
Sulfo-NHS-acetate modification:  
200 μl RPA, pRPA, RPA:ssDNA, or pRPA:ssDNA, were incubated with 300 μl 10 mM sulfo-
NHS-acetate stock solution for 80 min. The reaction was quenched by the addition 15 μl 
of 10 mM Glycine for each 10 μl of sample. Sulfo-NHS-acetate covalently modifies lysine 
residues in the protein (Figure 5)64. 
EDC glycine methyl ester modification: 
4 mM EDC and 5 mM glycine methyl ester was added to 1 mg/ml RPA, pRPA, 
ssDNA:RPA, or ssDNA:pRPA,  and incubated at room temp for 80 min. Reactions were  
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Figure 10. Dose dependence of the UV-B photo crosslinking of 5’6FAM poly T ssDNA 
30mer. Lane 1 is RPA with 0 exposure to UV-B. Lane 2 is RPA:ssDNA with 1,000 μJ UV. 
Lane 3 is RPA:ssDNA with 2,000 μJ UV. Lane 4 is RPA:ssDNA with 3,000 μJ UV. Lane 5 is 
RPA:ssDNA with 4,000 μJ UV. Lane 6 is RPA:ssDNA with 5,000 μJ UV. 
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quenched by the addition of 0.014 μl beta mercaptoethanol. The EDC glycine methyl 
ester reaction was used to covalently modify aspartate and glutamates within RPA and 
pRPA (Figure 5)62.  
Concentration with Bio-Rad protein Assay 
To determine the concentration of the purified fractions collected from each 
chromatographic elution step, for purified RPA, 10 μl aliquots were taken from each 
fraction and combined via standard protocols with Bio-Rad protein assay solution in a 96 
well plate. A Magellan uv/vis spectrophotmeter was used to scan the samples at a 595 
nm wavelength. The results were then compared to a BSA standard curve to determine 
overall protein concentration65 (Figure 11). 
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Figure 11. A Plot showing the concentration of Human Replication Protein A compared 
to a BSA standard curve after the final chromatographic step of purification. 
  
 
43 
 
  
0
0.02
0.04
0.06
0.08
0.1
0.12
0.14
0.16
0 0.25 0.5 0.75 1 1.25 1.5 1.75 2 2.25 2.5 BSA  
RPA 
 
44 
 
Fluorescence anisotropy 
To determine RPA and pRPA dT30 binding activity, a Magellan UV/VIS 
spectrophotometer was used to measure fluorescence anistropy (Figure 12). The 
activity of RPA was determined by monitoring the binding of a poly dT30mer with an 
attached 5’ 6FAM fluorophore to RPA. Increasing concentrations of 5’ 6FAM dT30mer 
were added to a fixed concentration of RPA. Specific anistropy of the fluorescent ssDNA 
oligomer was used to monitor oligonucleotide binding with each addition. As a control, 
BSA was loaded with the same substrates, and differences in anisotropy were 
evaluated65. Plotting the binding as a function of ssDNA concentration revealed a 
stoichiometric relationship (1:1) for binding to RPA and pRPAs’ association with the 
oligonucleotide with dissociation constants of approximately 1.7x10-9M and 2.0x10-10M 
for RPA and pRPA respectively, which was consistent with a single binding site (Figures 
13 & 14).  
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SDS-PAGE SDS-polyacrylamide gel electrophoresis was used to analyze fractions from 
the final step in the RPA purification (Figure 8). 10 μl of the purified hPRA 
chromatographic fraction were mixed with 15 ul SDS loading buffer, boiled for 10 min at 
90o C and loaded onto a 12% SDS-Polyacrylamide gel. Pageruler plus protein ladder was 
used as a molecular weight standard. All gels were electrophoresed at a 60 mA constant 
current using the Bio-Rad mini gel system. Gels were stained with coomassie blue and 
destained with standard wash and destain solutions. Gels were then imaged in a Bio-Rad 
Gel imager for final visualization.  
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Figure 12. RPA fluorescence anisotropy. Representative plot of a fixed concentration of 
human Replication Protein with an increasing concentrations of ssDNA. 
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Figure 13. Concentration dependence of ssDNA binding to RPA. Kd 1.7x10-9. Binding 
data from multiple runs were fit to a single site association model using a nonlinear 
regression analysis implemented on Slide Write. 
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Figure 14. Concentration dependence of ssDNA Binding to pRPA. Kd 2.0x10-10. Binding 
data from multiple runs were fit to a single site association model using a nonlinear 
regression analysis implemented on Slide Write.  
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Phosphate Imaging 
To verify the phosphorylation of RPA, putatively phosphorylated samples were collected 
and 10 μl aliquots were mixed with 15 μl of SDS loading buffer, boiled at 90o C for 10 
min, and then loaded onto a 15% SDS-polyacrylamide gel and electrophoresed at 60 mA. 
After electrophoresis the gel was stained with Pro-Q Diamond gel dye, a dye that 
specifically binds to phosphorylated peptides. The gel was then imaged in a Bio-Rad gel 
imager with specific filters for Pro-Q diamond to visualize bands containing the 
phosphorylated RPA (Figure 15). The gel was then destained and restained with Sypro 
Ruby protein stain and imaged on the Bio-Rad gel imager with filters for Sypro Ruby 
(data not shown). This allowed us to compare the total protein within the gel with 
phosphorylated protein, as well as to identify subunits of RPA which were 
phoshphorylated.  
Figure 15. SDS polyacrylamide gel of pRPA stained with Pro Q diamond. Lane 1 is the 
Pageruler plus protein ladder. Lane 2 is blank. Lane 3 is native RPA. Lane 4 is fraction 1 
of pRPA. Lane 5 is fraction 2 of pRPA. Lane 6 is fraction 3 of pRPA. Lane 7 is fraction 4 of 
pRPA. Lane 8 is BSA (naturally phosphorylated), a positive control for phosphorylation. 
Lane 9 is Lysozyme, a negative control for phosphorylation. 
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Fluorescein Imaging 
The UV crosslinked DNA-RPA substrate was collected and 10 μl aliquots were mixed with 
15 μl of SDS loading buffer and boiled at 90o C for 10 min. The samples were then 
electrophoresed on a 15% SDS-polyacrylamide gel, loaded onto a 15% SDS-
polyacrylamide and electrophoresed at 60 mA. The gel was then imaged in a Bio-Rad gel 
imager with special filters for Fluorescein to visualize bands containing the 5’ 6FAM dt 
30mer (Figure 16).  
Exhaustive in-gel Digestion 
Exhaustive in gel digestion was performed following the protocol of Shevchenko et al.66 
Excised gel bands corresponding to the 70, 32, and 14 kDa subunits of RPA and pRPA, 
were digested with the serine proteases trypsin and chymotrypsin. Proteomic grade 
porcine trypsin (1μg/μl) was used to cleave the carboxyl side of lysines and arginines 
and proteomic grade bovine pancreatic chymotrypsin (1μg/μl) was used to cleave the 
carboxyl side of leucine, methionine, phenylalanine, tryptophan, and tyrosines. For all 
experiments, the protein was digested to exhaustion over night at 37o C.  
The ssDNA:RPA and ssDNA:pRPA covalent adducts were resistant to proteolytic 
digestion, and required nucleolytic digestion by Micrococcal nuclease (10 μg 
nuclease/100 μg DNA) for 2 hrs. at 37o C prior to proteolysis.  
  
 
55 
 
Figure 16. SDS-polyacrylamide gel of ssDNA photo crosslinked with Human Replication 
Protein A. To image RPA covalently crosslinked with 5’ 6 FAM dt 30mer, the Bio-Rad gel 
imager was used with the fluoroscein filter. Lane 1 is the Pageruler plus protein ladder. 
Lane 2 is ssDNA. Lane 3 is ssDNA treated with 5000 μJ UV. Lane 4 is RPA. Lane 5 is RPA 
treated with 5000 μJ UV.  Lane 6 is RPA:ssDNA treated with 5,000 μJ UV.  Lane 7 is 
RPA:ssDNA treated with 5,000 μJ UV and digested with micrococcal nuclease.   
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Mass Spectrometry 
Mass spectra of RPA, pRPA, and its modified adducts was obtained using a Bruker 
Autoflex III MALDI-TOF/TOF mass spectrometer (Bruker Daltonics, Billrica, MA). Prior to 
MS analysis, Ziptips™ (c18) were used to remove contaminants and salt as well as 
enhance resolution and assignment of peptides. 10 μl of each sample was loaded on the 
tips and washed. Increasing concentrations of acetonitrile were used to elute peptides 
from Ziptips (c18). Concentrations of 10, 20, 30, 40, 50, 60, 70, 80, 90 and 100% 
acetonitrile were used to fractionally elute the peptides bound to the Ziptips. Each 
separate elution fraction was spotted and analyzed by mass spectrometry. Fractional 
elution provided greater resolution (sequence coverage for RPA) when compared to 
single concentration elution of peptides reported in mass spectroscopic analyses. Peaks 
corresponding to individual peptides were often present in 1 concentration of 
acetonitrile that were not detected in higher or lower concentrations. 1 μl of the eluate 
of each wash was mixed with 1 μl of 20 mg/ml CHCA (α-cyano-4-hydroxycinnamic acid).  
For each wash, 1 μl of each of the mixtures was spotted on a 384 spot-brushed steel 
plate from Bruker Daltonics (Bruker Daltonics, Brillica, MA) and allowed to dry. The 
spotted protein was analyzed in the mass spectrometer. Each spot was analyzed with 
20,000 laser shots aimed at different random locations in the same spot at 100% laser 
intensity with a gain of 15 in reflector mode.  
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MMass 
Mass spectral data were collected from the Bruker Autoflex III and analyzed 
using MMass open source software (MMass.org). Mmass is a software suite that 
performs a theoretical digestion of a protein primary sequence and assigns peaks within 
the observed spectra to the theoretical digest. Peptides were assigned with a tolerance 
of 1,000 ppm. Baseline correction was set to a precision of 5 with a relative offset of 15. 
Mass spectral data were smoothed via the Savitzky-Golay algorithm. Peak picking was 
performed with a signal to noise threshold of 5.0 and allowing for deisotoping. 
Representative results are shown in (Figures 17 & 18). After peak assignment, all data 
was compiled into tables showing observed peptides and those amino acids within the 
peptides covalently crosslinked to ssDNA (Tables 1, 2, & 3).  
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Table 1. Covalently crosslinked amino acids in the 70 kDa subunit of RPA and pRPA.  
Residues in the model with a calculated surface exposure of 30% or greater were 
considered exposed and colored green. Residues with a calculated surface exposure 
between 15-30% were considered partially exposed and colored yellow. Residues with a 
calculated surface exposure of less than 15% were considered buried and colored red. 
Residues that were the only site for crosslinking in a reported peptide but had a 
calculated surface exposure below 15% were colored yellow. For amino acids that were 
selected as a direct site of crosslinking, the box adjacent and right was painted blue. 
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Table 2. Covalently crosslinked amino acids in the 32 kDa subunit of RPA and pRPA.  
Residues in the model with a calculated surface exposure of 30% or greater were 
considered exposed and colored green. Residues with a calculated surface exposure 
between 15-30% were considered partially exposed and colored yellow. Residues with a 
calculated surface exposure of less than 15% were considered buried and colored red. 
Residues that were the only site for crosslinking in a reported peptide but had a 
calculated surface exposure below 15% were colored yellow. For amino acids that were 
selected as a direct site of crosslinking, the box adjacent and right was painted blue.  
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Table 3. Covalently crosslinked amino acids in the 14 kDa subunit of RPA and pRPA.  
Residues in the model with a calculated surface exposure of 30% or greater were 
considered exposed and colored green. Residues with a calculated surface exposure 
between 15-30% were considered partially exposed and colored yellow. Residues with a 
calculated surface exposure of less than 15% were considered buried and colored red. 
Residues that were the only site for crosslinking in a reported peptide but had a 
calculated surface exposure below 15% were colored yellow. For amino acids that were 
selected as a direct site of crosslinking, the box adjacent and right was painted blue.  
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Results 
Replication Protein A Purity 
To determine the purity of RPA and pRPA, fractions collected from the Q sepharose 
column, for RPA and pRPA were electrophoresed on 12% SDS polyacrylamide gels and 
visualized with Coomassie Blue gel dye. Bands were visible for both RPA and pRPA at 
molecular weights corresponding to 70 kDa, 32 kDa, and 14 kDa (Figures 8 & 9). 
Additionally, no contaminant bands that might correspond to truncated protein were 
observed. A total of roughly 2 mg of RPA was harvested from each purification. 
Activity 
To determine the activity of purified RPA and pRPA, binding experiments were 
performed in which fluorescence anisotropy was used to monitor association of the 
5’6FAM dT30mer with RPA. Concentration dependencies performed under 
stoichiometric binding conditions demonstrated approximately 80% of the purified RPA 
and pRPA are active in these preparations (Figure 12). SDS gel analysis indicated less 
than 5% impurity. Additionally, association constants for hPRA and pRPA binding to the 
5’6FAM poly dT30mer were determined by concentration dependancies of 
oligonucleotide association with RPA or pRPA. Binding data from multiple runs were fit 
to a single site association model using a nonlinear regression analysis implemented on 
Slide Write (Sigma Aldrich, St. Louis, MO). Dissociation constants of 1.7x10-9M and 
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2.0x10-10M for RPA and pRPA, respectively (Figures 13 & 14) were determined. These 
were consistent with previously reported binding experiments49.   
Phosphorylation 
Upon repurification of RPA subjected to phosphorylation from nuclear extracts from 
HeLa cells, samples were electrophoresed on 12% SDS polyacrylamide gels. The gel was 
stained with coomassie blue and bands were compared to native RPA to ascertain shifts 
in migration corollary to phosphorylation of RPA. Further, the gels were stained with the 
phospho-protein specific Pro Q diamond gel stain. The gels demonstrated shifts for the 
70 and 32 kDa subunits as well as fluorescence under the Pro Q diamond filters on a Bio 
Rad gel imager (Figure 15).  
UV Crosslinking 
To demonstrate that RPA or pRPA were covalently photo crosslinked to ssDNA 
containing a 5’ fluorophor, samples subjected to UV photo crosslinking in the 
Stratalinker photo crosslinker were electrophoresed on 15% SDS polyacrylamide gels. 
The gels were then imaged in a Bio Rad gel imager with specific filters for the fluorescein 
(Figure 16). These gels contained bands that represented the photo crosslinked species 
of both RPA and pRPA with the 5’6 FAM dT30mer. 
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Mass Spectrometry 
RPA, pRPA, ssDNA:RPA, and ssDNA:pRPA, samples were all subjected to mass 
spectrometric analyses. Spectra were obtained from individual gel samples of RPA, 
pRPA, ssDNA:RPA, and ssDNA:pRPA that were separated via gel electrophoresis and 
subjected to exhaustive in-gel proteolytic and nucleolytic digestion. Individual bands, 
which represent homogenous samples for the protein, or protein:ssDNA 
heteroconjugate were excised and eluted and subsequently spotted for mass spectral 
analyses to determine the presence of all peptides corresponding to the 70, 32, and 14 
kDa subunits within each sample. Representative results are shown in Figures 17 & 18. 
This analysis also ruled out contamination by other proteins within the sample sets as 
well as RPA that was not crosslinked for the ssDNA:RPA and ssDNA:pRPA studies. 
Further, mass spectroscopic peaks for the N and C termini for the 70, 32, and 14 kDa 
subunits were reported. This indicated that each subunit was present in its entirety and 
that the subunits were not cleaved or truncated for the modification reactivity analyses. 
Discussion 
We obtained highly purified RPA, pRPA, ssDNA:RPA, and ssDNA:pRPA. This assertion is 
validated by multiple experimental approaches that demonstrates that each preparation 
was pure and contained only the desired species of the protein. More so, as proven by 
dT30 binding experiments of RPA and pRPA, the protein is highly active. The Kd’s of 
1.7x10-9M and 2.0x10-10M correspond to previously reported data for RPA and pRPA  
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Figure 17. MMass spectra from covalent crosslink experiments of RPA. Example of 
Mother-Daughter peaks from the 14 kDa subunit of RPA corresponding to peptide 85-94 
(1231.3472 m/z) and 85-94 crosslinked with ssDNA (1554.3963 m/z). 
 
70 
 
 
  
 
71 
 
Figure 18. MMass spectra from covalent crosslink experiments of pRPA. Example spectra 
from 14 kDa subunit of pRPA: DNA showing Mother-Daughter peaks for peptide 88-94 
(861.2835 m/z and 1177.6874 m/z). 
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with dT30 with values reported at 7.6x10-9M and 6.2x10-9M67, 58, 68 respectively. Taken as 
a whole, this suggests that the protein is folded properly and represents the 
physiological structure of the RPA in solution. It is with these samples that all 
subsequent experiments described here were performed. They provided a solid 
foundation for the assessment of covalent photo crosslinking and covalent chemical 
modification reactivity analyses with Replication Protein A. 
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3. STRUCTURAL ANALYSIS OF HUMAN RPA COVALENTLY PHOTO CROSSLINKED 
TO SINGLE STRAND DNA.  
Introduction 
It is widely believed that RPA has 3 distinct single strand DNA binding modes61. 
The first involves small substrates of 8 nucleotides (nt) with low affinity binding, in 
which the ligand binds to DBDs A and B. The second is a longer substrate (13-22 nt) 
binding mode in which the ligand binds DBDs A, B, and C. While the third is a higher 
affinity 30 nt binding mode in which the ligand binds DBDs A, B, C, and D sequentially in 
the 5’ to 3’ direction. This attributes binding to only the 70 and 32 kDa subunits of RPA. 
While 14 kDa subunit is essential for function of the complete heterotrimer64, most 
proposed models denote the 14 kDa subunit serves exclusively as a structural element. 
However, Saintome et al46. reported that the 14 kDa subunit of RPA binds to ssDNA 
based on photo crosslinking, EMSA and Western analyses46.  
Here we expand upon previous studies by photo crosslinking of ssDNA with 
either RPA or phosphorylated human Replication Protein A to determine the specific 
peptides and amino acids involved in the direct crosslinking of RPA and pRPA with a 
bound 30 nt ssDNA. Measuring the change in mass of crosslinked peptides by mass 
spectrometric analysis identifies the amino acids in that are covalently bound with the 
crosslinked ssDNA ligand.  
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Results  
In experiments reported here, peptides in RPA containing crosslinked ssDNA 
were identified using mass spectrometry. These peptides contain amino acids that are 
theoretical sites of ssDNA crosslinking. For these theoretical sites to be reactive, they 
must be exposed and adjacent of the ssDNA. Structural models provide exposure 
information for the crystalline protein, but more specifically for the OB folds (putative 
sites for ssDNA binding) as well as other domain regions within the protein. Therefore, 
theoretical crosslinking sites in peptides which were identified as being crosslinked by 
reported mass spectrometry data, were identified (localized) in RPA structural models 
(Figure 19). Not all theoretical sites need to be in a ssDNA binding site. In fact, if one of 
several theoretical sites is within a nucleotide binding site, the crosslinking result is 
explained. If a residue is exposed in a protein model and outside a previously identified 
ssDNA binding site, yet must be reactive to explain crosslinking results, it may indicate a 
novel ssDNA binding site.  
Assignment of crosslinking to a specific amino acid in a peptide from the mass 
spectrometric data was informed by the solvent accessible surface area of the amino 
acid in both the crystallographicly derived 3KDF model (corresponding to the 14 and 32 
kDa subunits) and the M80PS model proposed by our lab8 (model for the full structure 
of RPA in the apo state). To rule out multiple reaction sites within one peptide, peptides 
corresponding to missed cut sites both immediately before or after the peptide 
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containing the amino acid in question were used determine the reactivity of amino acids 
on either side of the amino acid of interest. Data corresponding to reported mass 
spectra for covalently crosslinked amino acids in RPA and pRPA were placed into tables 
to compare the  
Figure 19. Ribbon model of M80PS. The Domains are colored according to the previous 
scheme (Figure 2) and amino acids covalently crosslinked with ssDNA are colored green, 
while phosphorylated amino acids were colored orange.  
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assigned sites of crosslinking to the proposed surface accessibility of the crosslinked 
amino acid in the M80PS model (Tables 1, 2, & 3).   
Evaluation of ssDNA crosslinked with RPA  
Data summarized in tables 1-3 were used to paint the x-ray crystallographicly 
derived model, 3KDF, which includes RPA’s 14 and 32 kDa subunits, resolution of 1.98Å 
(Figure 20). Model-dependent surface-exposure evaluation of amino acids covalently 
crosslinked to ssDNA allowed the identification of the most probable targeted amino 
acids within the corresponding models. By using in vitro experimentation, we either 
supported or refuted the position of the amino acid under the specific reaction 
conditions for the proposed model based on actual experimental data. 3KDF was 
selected as it is a minimal structure that represents a truncated species of RPA 
containing DBD E of the 14 kDa subunit. Surface exposure models corresponding to 
3KDF were also evaluated (Figure 21). The amino acids that were then chosen as 
candidate residues were painted green on the 3KDF structure of ribbon and surface 
models (Figs. 19 & 20). The data summarized in tables 1-3 were then used to paint 
M80PS ribbon and surface models of RPA proposed by Nuss et al (Figures 22 & 23, 
Tables 1, 2, & 3)8. This model was selected as it is a full structural model of RPA 
containing all amino acids, DBDs and subunits. To determine which amino acid within a 
peptide of interest was the most likely candidate for crosslinking, each amino acid  
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Figure 20. Ribbon model of 3KDF crystal structure painted according to scheme (Figure 
2) demonstrating targeted amino acids for ssDNA binding for both RPA and pRPA. 
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Figure 21. Surface model of 3KDF crystal structure painted according to scheme (Figure 
2) demonstrating targeted amino acids for ssDNA binding for both RPA and pRPA. 
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Figure 22. Ribbon models of M80PS of RPA and pRPA colored according to scheme 
(Figure 2) with covalently crosslinked amino acids. The putative binding sites are colored 
orange and covalently crosslinked amino acids colored in green. 
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Figure 23. Surface models of M80PS of RPA and pRPA colored according to scheme 
(Figure 2) with covalently crosslinked amino acids colored in green. 
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within a crosslinked peptide was evaluated based on calculated surface exposures, as 
determined through SPDBV software. Amino acids with a score of 30% or greater 
corresponded to exposed, as they represent enough of the amino acid projecting 
outward or on the surface of the protein to have interactions with chemical modifying 
reagents, those with a score of 15-30% corresponded to partially buried and were also 
selected as having enough surface exposure to react with chemical modifying reagents, 
and were chosen as candidate amino acids for the reactions8. Amino acids with less than 
15% exposure are considered buried and ruled out for the sake of this analysis. All 
interacting amino acids for the 70, 32, and 14 kDa subunits were evaluated based on the 
M80PS model. Again, the same criterion for selection, as based on predicted surface 
exposure was used to determine which amino acids were buried or exposed. Candidate 
amino acids were painted green on the model. Additionally, for the M80PS model, DBDs 
A & B were removed to show structural detail of the 14 kDa subunit within the models 
(Figures 24 & 25).   
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Figure 24. Ribbon models of M80PS of RPA and pRPA colored according to scheme 
(Figure 2) with putative binding sites colored orange, covalently crosslinked amino acids 
colored in green and DBDs A and B removed. 
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Figure 25. Surface models of M80PS of RPA and pRPA colored according to scheme 
(Figure 2) with putative binding sites colored orange, covalently crosslinked amino acids 
colored in green and DBDs A and B removed. 
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Covalently Crosslinked Amino Acids in the 70 and 32 kDa subunits 
Lysine, phenylalanine, tryptophan, and tyrosine are the primary reactive sites for 
photo crosslinking with the single strand thymidine 30 mer69. All peptides corresponding 
to covalently crosslinked ssDNA:RPA heteroconjugates contained these predicted target 
amino acids. Potential targets were selected as specific amino acids capable of 
covalently photo crosslinking with the ssDNA poly T 30mer within the observed peptide 
that contained a photo crosslink. When there was a covalent crosslink between ssDNA 
and a peptide and only 1 amino acid corresponded to those capable of crosslinking to 
ssDNA, then an assignment was made. When the data indicated a covalent crosslink 
within a peptide and there were 2 or more amino acids within the peptide capable of 
crosslinking with the ssDNA, we used several factors for the tentative identification of 
the bound amino acid. The first was to look at physical placement and surface exposure 
of the amino acids as based on the M80PS model. Those with surface exposures less 
than 15% were ruled out based on previous experimental protocol8. Amino acids that 
were in putative binding sites were of higher preference, as they were a more probable 
candidate amino acid than one on the back side of a binding pocket. The second was to 
look at peptides containing the amino acids of interest for the parallel experiment using 
a different protease. Many times, amino acids could be separated and reactivity 
identified based on the presence or absence of a crosslink in a peptide that contained 1, 
but not both of the ambiguous amino acids in the other experiment. The third was to 
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look at peptides within the same experiment that corresponded to missed cut sites and 
contained potential amino acids on either side of the most likely target for the reaction.  
Again, the reactivity of a particular amino acid, could be separated from the other in 
question. However, not all amino acid candidates for a specific crosslinking reaction 
could be assigned. In that case, both amino acids were considered potential targets for 
the reaction. The criterion for the assigned targets primarily corresponded to the amino 
acids within the potential target pool that were within the ssDNA binding groove of a 
DNA binding site of the subunit and have surface exposures above the 15% threshold 
necessary for the photo crosslinking reaction (Tables 1 & 2). In some instances, peptides 
containing a covalent ssDNA crosslink were outside of putative binding sites. Again, the 
selection criteria previously mentioned was used to determine which amino acids were 
the most likely candidate if more than 1 potential target was within the peptide.  
When evaluating data from ssDNA:RPA, there were 58 candidate amino acids in 
the 70 kDa subunit of RPA covalently crosslinked with ssDNA (Table 1). Of those 58 
candidates, 41 were assigned as targets for crosslinking. Amino acids that were not 
chosen were in portions of the peptide that were outside the reported DBDs for each 
subunit or were in portions of the protein that were not accessible for interaction based 
on the structural models of the protein. In the 70 kDa subunit of the ssDNA:pRPA 
heteroconjugate, there were 53 candidate amino acids, 41 of which were selected as 
targeted amino acids for covalent crosslinking (Table 1). In the N terminus of the 70 kDa 
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subunit of RPA and the adjacent linker region connecting DBD F to DBD A, there were 4 
covalently crosslinked amino acids that were not present in the ssDNA:pRPA 
heterconjugate (42, 88, 103, and 111). Of the remaining discrepancies between the 
ssDNA:RPA heteroconjugate and the ssDNA:pRPA heteroconjugate, the specific amino 
acid targets coincided with peptides that are parts of DBDs A, B, &C, and are within the 
same DBDs in the 70 kDa subunit (Table 1) residues 222, 253, 280, 302, 379,528, 532, 
and 567. The minor variations between bound amino acids appear to represent local 
structural changes within these subdomain regions.  
In the 32 kDa subunit of the ssDNA:RPA heteroconjugate, there were 15 
candidate amino acids, of which, 12 were selected as amino acids is predicted 
interaction sites (Table 2). Again, amino acids that were not chosen were in portions of 
the peptide that were outside the reported DBDs for each subunit or were in portions of 
the protein that were not accessible for interaction based on the structural models of 
the protein. In the 32 kDa subunit of the ssDNA:pRPA heteroconjugate, there were 21 
candidate amino acids, with 18 being selected as amino acids in predicted interaction 
sites (Table 2). The ssDNA:pRPA heteroconjugate contained 5 amino acid targets within 
the N-terminal region that were not present in the native ssDNA:RPA heteronconjugate 
(residues 2, 6, 9, 14, and 20). Additionally, 3 amino acids, (155, 171, and 194) were 
selected as targets in ssDNA:pRPA that were not present in ssDNA:RPA.  
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Covalently Crosslinked Amino Acids in the 14 kDa Subunit 
Within the 14 kDa subunit of RPA in the 3KDF model, there were 9 amino acids 
within the peptides that were covalently crosslinked, of those 6 were selected as amino 
acids within predicted interaction sites, with at least 1 being present in each peptide 
with a surface exposure greater than 15% (Table 3). Within the 14 kDa subunit of pRPA 
in the 3KDF model, there were 11 amino acids within the peptides that were covalently 
crosslinked, of those 7 met the selection criteria as amino acids within predicted 
interaction sites, with at least 1 being present in each peptide with a surface exposure 
greater than 15% (Table 3). 9 amino acids were present in the 14 kDa subunit of RPA for 
the M80PS model. Again, 6 were selected as target amino acids (Table 3). 5 of the 
targeted amino acids had surface exposures of 15% or higher, and 1 amino acid (residue 
104) corresponded as a buried amino acid within the M80PS, but was the only target 
amino acid within the peptide. 12 amino acids were present in peptides within the 14 
kDa subunit of pRPA for the M80PS model. 6 amino acids were selected as covalently 
crosslinked amino acids (Table 3). 5 of the targeted amino acids had surface exposures 
greater than 15% and 1 amino acids were scored as buried, but was the only targeted 
amino acid within the covalently crosslinked peptide (residue 104). While both RPA and 
pRPA have 6 targeted amino acids, 3 of which differ between the 2 states. In RPA K 33 
and K 39 are targets, but are not covalently crosslinked in pRPA (Table 3). Likewise, K 76 
is covalently crosslinked in pRPA but not in RPA (Table 3). This suggests that the portion 
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of DBD E that is accessible for the interaction varies between the 2 states, and suggests 
conformational differences between the two structures resulting from the 
phosphorylation, or potentially represents the rearrangement of domains within the 
protein between the two reaction states. It should be noted, that 4 of the 6 amino acid 
targets are the same, and that the differences could represent a marginal 
rearrangement of the DBD between the 2 states.  
Discussion 
Single strand DNA binding activity involving the 70 and 32 kDa subunits of RPA is 
well known with established binding affinities for each DBD within the subunits30. With 
the exception of the covalently crosslinked amino acids of DBD F of the N-terminus of 
the 70 kDa subunit of ssDNA:RPA, and the N terminal amino acids of the 32 kDa subunit 
of ssDNA:pRPA, there were only minor differences between the target amino acids 
covalently crosslinked in the native and phosphorylated states of the protein. However, 
ssDNA crosslinking involving DBD F of RPA was unexpected. It implies that DBD F is in 
close proximity to the ssDNA substrate and in a conformation that places the ssDNA 
near the binding pocket of DBD F. This is consistent with the M80PS model which has 
the putative binding site in DBD F closely positioned to DBD D in the 32 kDa subunit. In 
the ssDNA:pRPA heteroconjugate, the absence of binding in this region suggests that 
the binding pocket of DBD F is occluded or juxtaposed away from the ssDNA substrate. 
The opposite is true for the binding of the N terminus of the 32 kDa subunit. Binding of 
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the 32 N terminus in pRPA to ssDNA necessitates that this region of the phosphorylated 
species lies in proximity to ssDNA and presents the adjacent binding pocket of DBD D for 
this reaction. The absence of binding in the unphosphorylated species suggests that this 
region does not present favorable amino acids for the covalent crosslinking reaction. 
The individual differences in the remaining data points in both the 70 kDa subunit and 
the 32 kDa subunit could represent minor local changes in each binding site that are 
affected by changes in local position of amino acids or potentially represent differing 
electrostatic potential of the phosphorylated protein versus the native protein. As a 
whole, this data fits traditional models and corresponded to previously reported DNA 
binding sites for the subunits70.  
Currently, the 3 proposed modes of binding for RPA to ssDNA are for varying 
lengths of substrates, and progress in the 5’-3’ direction starting with the DBD A of the 
70 kDa subunit and progress through DBDs B and C then to DBD D of the 32 kDa 
subunit5. Here we show direct covalent crosslinking of ssDNA with the DBD E of the 14 
kDa subunit. This interaction gives insight into the juxtaposition of the 70 kDa subunit 
with respect to the 14 kDa subunit. In a proposed model of apo RPA by Nuss et al.8, the 
DBDs A and B of the 70 kDa subunit are tethered to the trimerization core and occlude 
the nucleotide binding site of the 14 kDa subunit. Our results, reported here, provide an 
insight into potential structural rearrangements of the high affinity DBDs A & B in RPA 
and pRPA, which would allow these domains to undock from or reposition on the 
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trimerization core, thus freeing DBD E, of the 14 kDa subunit of RPA, for binding to a 30 
nt ligand. Removing DBDs A & B of the 70 kDa subunit from the M80PS model 
demonstrated the accessibility of the 14 kDa subunit when these DBDs are not directly 
juxtaposed to the trimerization core. With the removal of DBDs A & B, DBD E of the 14 
kDa subunit is directly accessible for interaction with ssDNA (Figures 24 & 25). More 
specifically, the amino acids covalently photo crosslinked to ssDNA are within the β 
barrel of DBD E and the α-helix proximal to it, which represent the putative binding site 
on the DBD (Figure 22). This suggests that a structural rearrangement from the unbound 
molecule to the bound state is necessary. This is consistent with the positioning of the A 
& B domains in a crystal structure of the RPA homologue in U. maydis proposed by 
Pavletich et al71, as well as structural models proposed by the Chazin lab,72. It further 
demonstrates the role of the 14 kDa subunit, while essential for the formation of the 
protein, surpasses a solely structural relationship to the 70 and 32 kDa subunits. The 
evolutionary conservation of the DBD E within the 14 kDa subunit in all RPA homologues 
again suggest that this portion of the protein is more than structural in nature73. Direct 
binding of the 14 kDa subunit implies a 4th mode of binding, or at the very least a 
modified 3rd mode for the full length 30 nt ligand. The putative binding site on DBD E is 
positioned opposite from DBD D of the 32 kDa subunit. The distance separating DBDs C 
& D and DBD E of the 14 kDa subunit would prevent a ligand of 30 nt in length from 
simultaneously binding DBDs A, B, C, D and E. This suggests that DBD E might bind 
 
99 
 
ssDNA independently of the previously reported mode in which a 30 nt ligand 
concurrently binds DBDs A, B, C, and D. In further support of this independent mode of 
binding, is the placement of DBD C. DBD C lies between the putative binding sites of 
DBD D and DBD E. The ssDNA ligand would have to bend around the molecule to 
simultaneously bind DBD C, D, and E, which strays from the traditional belief that the 
ssDNA ligand is straight and does not conform to the structure of RPA74. 
Phosphorylated RPA serves a different function within the cell from that of the 
unphosphorylated protein49. It is involved in DNA damage repair, while the 
unphosphorylated heterotrimer is involved in DNA replication and check point 
signalling6. Phosphorylation involves the N terminus of the 32 kDa subunit, as well as 
portions of the 70 kDa subunit48. Investigators have suggested that this phosphorylation 
leads to an extended conformation for the amino acids within these regions of the 
protein48. This structural rearrangement may cause minor perturbations within the 14 
kDa subunit as well. This is suggested by the differing peptides that are available for 
covalent photo crosslinking of the 30 nt ligand in the N terminus of the 70 kDa subunit 
of RPA, as well as the N terminus of the 32 kDa subunit of pRPA which are in close 
proximity to DBD E on the 14 kDa subunit.  
The data reported here cannot accommodate current models for the structure of 
phosphorylated. Local rearrangement of DBDs is necessary to explain the reactions with 
amino acids that are buried within the reported structures. Specifically, rearrangement 
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of amino acids in DBD F as well as the N terminus of the 32 kDa subunit would more 
accurately fit our experimental data.  
While it is clear that RPA plays a vital role in DNA regulation, maintenance, and 
repair, the role of the 14 kDa subunit remains uncertain. Demonstration of the 14 kDa’s 
ability to bind to ssDNA suggests that there may be a physiological role for this subunit 
that remains to be determined5,52. Attachment of ssDNA with DBD E of the 14 kDa 
subunit would aid continuing processivity of the molecule through replication. 
Additionally, this attachment would provide greater adhesion to the DNA if the N-
terminus of 70 interacts with p53 in the DBD F of the 70 kDa subunit in the presence of 
DNA damage75. Binding of DBD E would allow DBD A and DBD B to detach and bind to 
different sites along the DNA strand without detaching the heterotrimer from the DNA. 
The data reported here extended the work of Saintome et al.46 We demonstrated 
the interaction of the 14 kDa subunit with ssDNA in RPA and pRPA. Further, we 
identified the direct sites amino acid ssDNA binding within DBD E for both RPA and 
pRPA. The amino acids reported as binding to ssDNA were within the OB fold of the 
putative binding site of DBD E. This is consistent with ssDNA binding in the OB folds of 
DBDs A, B, C, and D.   
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4. STRUCTURAL ANALYSIS OF HUMAN REPLICATION PROTEIN A AND 
PHOSPHORYLATED HUMAN REPLICATION PROTEIN THROUGH CHEMICAL 
MODIFICATION REACTIVITY ANLAYSIS AND COVALENT PHOTO CROSSLINKING OF 
SINGLE STRAND DNA 
Introduction 
RPA is relatively large (116 kDa) and contains regions classified as inherently 
unstructured that link multiple domains within the protein71 (Figure 26). These 
characteristics limit the ability to determine the full heterotrimeric structures of RPA by 
x-ray crystallography and NMR. While it is believed that binding DNA causes structural 
rearrangement of RPA, many of the changes are still vague72,43. More so, structural 
rearrangement of the molecule in the phosphorylated state is also poorly understood6. 
To address this problem, an extensive literature and structural search was conducted to 
determine a list of areas of subunit-subunit and domain-domain interactions identified 
in select available crystal and NMR structures of Replication Protein A 
fragments71,72,76,60,19. Here, through the use of direct in vitro experimentation by 
chemical modification reactivity analyses, we evaluated the sites of subunit-subunit and 
domain interaction for RPA and pRPA in ssDNA free and ssDNA bound reactive states.  
Results 
RPA structural models reported from all available crystal and NMR structural 
studies for Replication Protein A were used to identify regions of subunit and domain  
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Figure 26. Structural model of RPA.  The view of the structural model in the right panel is 
rotated 90
o 
about a vertical axis relative to the left panel view.  Domains are indicated by 
tubes. The α-trace of non-domain regions generated by simulated annealing are 
represented as stick figures.   
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surfaces involved in subunit-subunit and domain-domain interactions. Specifically, 
aspartates, glutamates, and lysines that reside within the portions of the models that  
are involved in subunit-subunit and domain-domain interactions were then probed by in 
vitro chemical modification (Table 4). The chemical modification reactivity of these 
amino acids were then evaluated on a kinetic basis to determine susceptibility and rate 
of modification, which provided greater detail for the reactions of the amino acids in the 
inter subunit and inter domain interacting sites (Table 4). Evaluating the chemical 
modification reactivity data allowed us to infer conformational changes in the protein’s 
structure. While all reported crystal and NMR structures were used to determine the list 
of amino acids for MRAN, none of these structures correspond to the full native or 
phosphorylated protein. Therefore, choosing of the amino acids for this study was 
primarily informed by a structural model proposed by Nuss et al8., (Figure 2). This model 
was built in an additive process in which a core structure was assembled, and remaining 
domains and inter domain sequences were placed so their position was consistent with 
chemical modification results and docking free energy calculations previously reported8.  
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The resulting data from chemical modifications in this study was then used to 
judge the relevance of the reported three dimensional models of human Replication 
Protein A (Figure 27). Relevant fit of the residues in the proposed structures were 
evaluated on the basis of its reactivity relative to its surface accessibility and exposure in 
the structural model. X-ray crystal and NMR structures were evaluated on a residue by 
residue basis to determine if experimental data coincided with the proposed structures.  
The models that were most consistent with experimental data were selected. Further, 
the data suggested how a selected model could be altered to conform to modification 
results and more accurately describe the residue and molecule in solution state. The 
data for these models was collected for each residue when RPA was in several 
physiologically important states including: native, phosphorylated, bound with ssDNA, 
and phosphorylated and bound with ssDNA. 
The previous studies identifying ssDNA binding sites (Chapter 3 in this 
dissertation) suggest changes in packing of DBD A and DBD B concomitant with DNA 
binding in the complete protein. Yet, it provides no information about novel interaction 
sites of these domains with the rest of the protein10,77. More so, for the other DNA 
binding domains of RPA, (C, D, E, & F), the structure of the domains in RPA fragments 
has not been reported in the presence of DNA, though they have in its absence19,43. Our 
lab has proposed the full structure of RPA in the absence of ssDNA8, and suggested 
interactions between all domains in this state. Understanding the interactions of these 
 
106 
 
Figure 27. Ribbon model M80PS. Domains are colored according to the previous scheme 
(Figure 2), while aspartates, glutamates, and lysines that were covalently chemically 
modified by EDC glycine methyl ester or sulfo-NHS-acetate were colored magenta.  
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Table 4. Kinetic evaluation of residues of interest and amino acids in inter domain and 
inter subunit sites for the 70, 32, and 14 kDa subunits of RPA.  
Very Reactive residues were colored green. Reactive residues were colored yellow. 
Unreactive residues were colored red. Sites where there was no data for a reaction was 
colored white.  
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Subunit AA RPA ssDNA:RPA pRPA ssDNA:pRPA 
14 3 reactive reactive reactive reactive 
14 22 reactive unreactive reactive unreactive 
14 23 reactive reactive reactive reactive 
14 33 reactive reactive reactive reactive 
14 45 reactive reactive reactive reactive 
14 49 reactive unreactive reactive unreactive 
14 54 reactive reactive reactive reactive 
14 57 reactive reactive reactive reactive 
14 68 reactive reactive reactive reactive 
14 76 reactive reactive reactive reactive 
14 95 reactive unreactive reactive unreactive 
14 104 unreactive reactive unreactive reactive 
14 108 reactive reactive reactive Reactive 
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Subunit AA RPA ssDNA:RPA pRPA ssDNA:pRPA 
32 7 very reactive reactive reactive reactive 
32 36 reactive no data no data no data 
32 37 no data no data very reactive no data 
32 38 no data no data very reactive no data 
32 62 reactive reactive reactive reactive 
32 70 reactive reactive unreactive reactive 
32 84 reactive reactive reactive reactive 
32 85 very reactive reactive reactive unreactive 
32 95 reactive unreactive reactive reactive 
32 96 reactive unreactive reactive reactive 
32 103 reactive unreactive reactive reactive 
32 111 reactive reactive reactive reactive 
32 112 reactive reactive reactive reactive 
32 127 very reactive very reactive very reactive no data 
32 139 reactive reactive reactive reactive 
32 145 unreactive no data no data no data 
32 151 unreactive unreactive unreactive reactive 
32 154 unreactive unreactive unreactive reactive 
32 171 very reactive very reactive very reactive very reactive 
32 217 unreactive no data no data no data 
32 223 reactive reactive very reactive very reactive 
32 229 reactive reactive unreactive reactive 
32 231 unreactive very reactive no data no data 
32 235 reactive very reactive reactive no data 
32 243 reactive very reactive reactive no data 
32 247 reactive reactive reactive reactive 
32 252 reactive unreactive reactive reactive 
32 260 very reactive reactive reactive reactive 
32 261 very reactive reactive reactive reactive 
32 262 very reactive reactive reactive reactive 
32 265 very reactive no data reactive no data 
32 268 very reactive reactive reactive reactive 
32 270 very reactive reactive reactive Reactive 
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Subunit AA RPA ssDNA:RPA pRPA ssDNA:pRPA 
70 7 very reactive very reactive very reactive very reactive 
70 16 reactive no data reactive Reactive 
70 18 reactive reactive reactive reactive 
70 23 very reactive no data very reactive very reactive 
70 48 very reactive reactive reactive reactive 
70 67 reactive reactive reactive reactive 
70 68 reactive reactive reactive reactive 
70 69 reactive reactive reactive reactive 
70 88 reactive no data no data no data 
70 89 reactive reactive very reactive reactive 
70 98 reactive reactive reactive very reactive 
70 100 reactive reactive unreactive reactive 
70 103 reactive reactive no data reactive 
70 106 reactive reactive reactive reactive 
70 111 reactive reactive no data reactive 
70 183 reactive reactive reactive no data 
70 229 reactive reactive reactive reactive 
70 230 reactive reactive reactive reactive 
70 259 reactive reactive reactive reactive 
70 263 reactive unreactive reactive unreactive 
70 277 unreactive reactive reactive reactive 
70 290 reactive reactive reactive no data 
70 307 reactive unreactive unreactive reactive 
70 309 reactive reactive reactive reactive 
70 318 reactive reactive reactive reactive 
70 343 reactive no data reactive unreactive 
70 354 reactive no data reactive reactive 
70 404 reactive reactive reactive reactive 
70 406 reactive reactive reactive reactive 
70 410 reactive reactive reactive reactive 
70 416 reactive reactive reactive reactive 
70 418 reactive reactive reactive reactive 
70 429 reactive reactive reactive reactive 
70 469 reactive unreactive unreactive reactive 
70 489 reactive unreactive no data no data 
70 501 reactive reactive reactive reactive 
70 551 reactive no data no data no data 
70 555 reactive reactive reactive reactive 
70 577 reactive unreactive reactive very reactive 
70 588 reactive unreactive no data reactive 
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domains in the presence of ssDNA will provide greater insight into the arrangement of 
the molecule and suggests how that arrangement modulates the protein’s function 
when RPA is bound to DNA. To evaluate this RPA state, a list of potential amino acid 
targets in these regions is of particular interest since any rearrangement of domains 
would presumably change these amino acids’ reactivity. In addition, potential target 
amino acids in DNA binding sites are of interest since their reactivity should change in 
the presence of bound DNA, if only by being bound to DNA.  
To assure that all appropriate RPA and pRPA nucleotide binding sites were 
occupied by ssDNA throughout modification reactivity analyses, we covalently photo 
crosslinked ssDNA 5’6FAM poly T 30mer to RPA or pRPA. Isolating these RPA or pRPA-
ssDNA adducts assured that only protein containing ssDNA was used in experiments. 
These covalently bound protein-nucleotide heteroconjugates were used for covalent 
chemical modification experiments designed to probe the structure of ssDNA bound 
RPA and ssDNA bound pRPA78. To determine sites of heteroconjugate formation as well 
as identify amino acids that were covalently modified via MRAN in these experiments, 
SDS polyacrylamide electrophoresis and in gel digestion was used in conjunction with 
mass spectrometry to determine the locations of ssDNA binding and to evaluate the 
chemical reactivity of the amino acids selected in the inter domain interacting sites and 
infer structural differences among the various ligand binding sites under differing 
experimental conditions. 
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Data assessment and pairwise comparison tables 
Reaction products were analyzed using mass spectroscopy. Spectra results were 
evaluated using Mmass software (MMass.org) and results were used to create a series 
of tables in which covalent photo-crosslinking, covalent chemical modification, and 
phosphorylation states were compared among the different RPA ligand binding states. 
Chemical modification of the aspartates, glutamates, and lysines within peptides within 
in the 70, 32, and 14 kDa subunit interaction sites of RPA and pRPA were determined. 
Lysines covalently chemically modified by sulfo-NHS acetate increased their mass by 42 
daltons64. Peptides containing aspartates and glutamates and modified by EDC and 
glycine methyl ester increased their mass by 124 daltons for each amino acid covalently 
chemically modified62. The change in mass between the native unmodified peptide to 
that of a chemically modified peptide, as ascertained via mass spectrometry, was then 
used to identify each amino acid that was modified in the peptide. Photo crosslinking of 
ssDNA polyT 30mer resulted in a net gain of 321 daltons for each thymidine that was 
covalently crosslinked with an amino acid within the peptide27. Lastly, phosphorylation 
of serines and threonines within the 70, 32, and 14 kDa subunits of phosphorylated RPA 
was identified. Phosphorylation of serines and threonines resulted in a net increase of 
80 daltons for each amino acid that was modified in a peptide48. Methionine and 
tryrosine residues are also potential targets of phosphorylation, but were not found 
within the spectra collected27. The data collected for the measured reactivities and 
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modifications were then organized into pairwise comparison tables for direct 
comparison of chemical modifications, phosphorylations, and covalent crosslinks of 
ssDNA between RPA and ssDNA:RPA (Table 8), pRPA and ssDNA:pRPA (Table 9), RPA and 
pRPA (Table 10), and ssDNA:RPA and ssDNA:pRPA (Table 11). Additionally, a table was 
created that compared the predicted surface exposure of amino acids in crystal,  
NMR, and proposed models of RPA to evaluate the relevance of those models to the 
modification results reported here (Table 5 & 6). 
The surface exposure for each modified amino acid was calculated using SPDBV 
for the crystal, and NMR structures corresponding to fragments of RPA. Specifically, 
1JMC, 1L1O, 1FGU, 1DPU, 3KDF, 1EWI, 4R4C, M80PS, and 4GNX were used. The tables 
for chemical reactivity, photo crosslinking, and phosphorylation were then compared to 
calculated surface exposure to ascertain whether the model fit the reported 
experimental data as well as what changes are necessary for the model to account for 
differences between the model and experimental data.   
 
Kinetic evaluation of MRAN analyses of Replication Protein A 
Even with a single-time measurement of a chemical modification reaction, 
(rather than a full time course), it is possible to classify reactions in one of three 
categories, on the basis of kinetics. If only the product was found then the reaction was 
fast relative to the time of observation and was scored very reactive, if only the 
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reactants were found then the reaction is slow, relative to the observation time and was 
scored unreactive, and if both product and reactant were observed, then the reaction 
proceeds at an intermediate rate and was scored reactive. It follows, that if multiple 
reactions are measured at the same time under identical conditions, these reactions can 
be grouped in the categories just mentioned and compared with each other. A rubric 
was established to score the reactivities of individual amino acids within a peptide 
(Table 12). Relative signal intensity in mass spectrometry depends on several molecular 
characteristics other than relative molar quantity. In fact, specific products or reactants 
might not be observed under particular instrumental conditions. Since chemical 
modification changes these features, it is risky to quantify reactions based on relative 
amplitudes. However, the presence of mass spectral peaks indicating the presence or 
reactant, product, or both still allows for the classification scheme just described.   
Number of very reactive, reactive, and nonreactive sites in a peptide A 
complication occurs in measuring the reaction of peptides, as is done here, rather than 
individual amino acids. If multiple reactions occur in the peptide, then multiple products 
are expected. With the assumption that reactions occur at each site in the protein 
independently, the expected products will simply be the sum of those expected at each 
reactive/potentially reactive site (i.e. for a peptide with two reactive sites, mass peaks 
corresponding to two modification, one modification, or no modification might be 
produced). In addition, the most conservative application of this analysis should also 
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allow that an expected MS peak might not be seen because the corresponding peptide 
“did not fly”, or has a charge (negative) inconsistent with acceleration and detection 
systems of the mass spectrometer.  Based on the considerations just described, we 
predicted which molecular species would be produced (and corresponding mass 
spectral peaks seen) if a peptide generated by cleavage of a protein previously modified 
by a reagent contains one, two, three, four, or more modification sites, assuming that 
each modification site can be very reactive, unreactive, or moderately reactive . If one 
or more products predicted for a particular extent of modification was observed this 
extent of modification was considered a potential product (group of products). If more 
than one extent of modification was found then these were all considered as possible 
products. 
Assignment of a reactivity to a single amino acids 
When multiple modification sites occur in a single peptide, and the analysis just 
described indicated that a specific number of very reactive, reactive, and unreactive 
sites were present, assignment of a reactivity class to a particular amino acid frequently 
required considering the reactivities of neighboring peptides in the primary structure. 
Neighboring peptides can often contain 1 or more of the amino acid targets for chemical 
modification that are within the peptide of interest. By determining the reactivity of 
these amino acids independently from the peptide containing the amino acids of 
interest, the reaction 
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Table 5. Comparison of chemical modification reactivity data for the EDC glycine methyl 
ester reaction to the proposed models.  
Corresponding data reported here for the M80PS structure, as well as reported crystal, 
and NMR models for fragments of RPA are shown. The listed structure is placed under 
each reaction that corresponds to a match with its available surface exposure and the 
reported result from chemical modification reactivity analyses. Residues within a 
structure with a surface accessibility of 30% or higher (considered reactive for this study) 
were colored green. Residues within a structure with a surface accessibility between 15-
30% (considered reactive for this study) were colored yellow. Residues within a structure 
with a surface exposure below 15% (considered unreactive for this study) were colored 
red. As 4GNX is the structure of a human RPA homologue from U.maydis, not all residues 
were the same, and therefore were not targets for chemical modification. When U. 
maydis did not have a homologous aspartate, glutamate, or lysine it was noted in blue.  
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Table 6. Comparison of chemical modification reactivity data for the sulfo-NHS-acetate 
reaction to the proposed models. 
Corresponding data reported here for the M80PS structure, as well as reported crystal, 
and NMR models for fragments of RPA are shown. The listed structure is placed under 
each reaction that corresponds to a match with its available surface exposure and the 
reported result from chemical modification reactivity analyses. Residues within a 
structure with a surface accessibility of 30% or higher (considered reactive for this study) 
were colored green. Residues within a structure with a surface accessibility between 15-
30% (considered reactive for this study) were colored yellow. Residues within a structure 
with a surface exposure below 15% (considered unreactive for this study) were colored 
red. As 4GNX is the structure of a human RPA homologue from U.maydis, not all residues 
were the same, and therefore were not targets for chemical modification. When U. 
maydis did not have a homologous aspartate, glutamate, or lysine it was noted in blue.  
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products for the chemical modification of the peptide of interest can be separated. A 
unique amino acid assignment was frequently found in this way. Even when a complete 
assignment cannot be made, some possibilities are often eliminated. When multiple 
targets occurred in a peptide, which analysis indicated had different reactivities, the 
assignment of reactivities to specific residues also took into consideration predicted 
surface exposures for the amino acids in various structural models. The models used to 
select the amino acids included the M80PS model, produced in our laboratory8, 1JMC 
(which is a crystal structure of DBDs A & B, of the 70 kDa subunit, bound to ssDNA), 
1DPU (the C terminus of the 32 kDa subunit), and 1L1O (the trimerization core of RPA, 
consisting of the 14 kDa subunit, a truncated 32 kDa subunit missing the N and C 
termini, and DBD C on the C terminus of the 70 kDa subunit). 
This method was then used to measure the chemical modification reactive states 
of the inter domain interaction sites between DBDs A & B, as well as the N terminus of 
the 70 kDa subunit to better understand the positioning of DBDs A & B and the N 
terminus of the 70 kDa subunit on the surface of the trimerization core, which contains 
DBDs C, D and E (Table 4).  
Modified Residue Structural Comparisons 
Comparisons of the reactivity of the same RPA residues when the protein is in 
different DNA binding and phosphorylation states are summarized in the pairwise 
comparison tables (Tables 8, 9, 10, & 11). Reactivities were judged using the previously 
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mentioned criterion for a reaction with a modifying. A residue by residue classification 
for each reaction state was used to determine whether any structural changes occurred 
between the various RPA ligand binding states. A total of 48 reactive amino acids were 
probed in the 3 subunits of RPA, 8 of which were in the 14 kDa subunit, 12 were in the 
32 kDa subunit, and 28 were in the 70 kDa subunit (Table 7). 
RPA vs ssDNA:RPA 
  In comparing RPA and ssDNA:RPA (Table 8), the 14 kDa subunit had 2 amino 
acids, aspartate 22 and lysine 49, which were modified in RPA but were not modified in 
the ssDNA:RPA (Figures 28 & 29). The 32 kDa subunit contained 1 amino acid that had 
differing reactivity between the 2 states, aspartate 103. In RPA, aspartate 103 was 
modified, however, no modification occurred when DNA was bound. In the 70 kDa 
subunit lysine 88, lysine 263, lysine 273, lysine 379, and aspartate 307 were modified in 
the RPA, but not in ssDNA:RPA.  
pRPA vs ssDNA:pRPA  
In the comparison between the pRPA and ssDNA:pRPA, (Table 9), again, 
aspartate 22 and lysine 49, in the 14 kDa subunit, were modified in pRPA and were not  
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Table 7. Residues of Interest for the 14, 32, and 70 kDa subunits of Human Replication 
Protein A.  
These residues were the primary residues probed in the pairwise comparison tables 
between the different RPA reactive states.  
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Subunit Glu/Asp Lys 
14 3 23 
 
22 33 
 
54 49 
 
57 76 
   32 7 85 
 
36 171 
 
62 
 
 
70 
 
 
84 
 
 
103 
 
 
111 
 
 
112 
 
 
261 
 
 
270 
 
   70 68 88 
 
229 111 
 
230 183 
 
290 244 
 
307 257 
 
309 264 
 
404 273 
 
407 313 
 
416 341 
 
418 354 
 
469 379 
 
501 410 
 
555 467 
  
481 
  
498 
  
551 
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Table 8. Comparison of chemical modification reactivities between native RPA and 
ssDNA:RPA. 
 Amino acids that were chemically modified were colored green Amino acids that were 
not modified were colored red. Amino acids that were crosslinked to ssDNA only were 
colored blue. Sites were there was no data for an amino acid was colored white.  
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Table 9. Comparison of chemical modification reactivities between pRPA and 
ssDNA:pRPA. 
Amino acids that were chemically modified were colored green Amino acids that were 
not modified were colored red. Amino acids that were crosslinked to ssDNA only were 
colored blue. Sites were there was no data for an amino acid was colored white.  
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Table 10. Comparison of chemical modification reactivities between RPA and pRPA. 
Amino acids that were chemically modified were colored green Amino acids that were 
not modified were colored red. Amino acids that were crosslinked to ssDNA only were 
colored blue. Sites were there was no data for an amino acid was colored white.  
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Table 11. Comparison of chemical modification reactivities between ssDNA:RPA and 
ssDNA:pRPA. 
Amino acids that were chemically modified were colored green Amino acids that were 
not modified were colored red. Amino acids that were crosslinked to ssDNA only were 
colored blue. Sites were there was no data for an amino acid was colored white.  
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Figure 28. View of Lys 49 in the putative binding site of the 14 kDa subunit in the M80PS 
ribbon model. Domains are colored according to the previous scheme (Figure 2). This 
residue is blocked by DBD B in the native state, but is covalently crosslinked to ssDNA in 
the bound state. 
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Figure 29. View of Asp 22 in the putative binding site of the 14 kDa subunit in the M80PS 
ribbon model. Domains are colored according to the previous scheme (Figure 2). Asp 22 
is blocked by DBD A in the native state, but is covalently crosslinked to ssDNA in the 
bound state.  
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Figure 30. View of Glu 70 in the 32 kDa subunit in the M80PS ribbon model. Domains are 
colored according to the previous scheme (Figure 2). Glu 70 is not modified in the pRPA 
state but is modified in the ssDNA:pRPA state. Glu 70 is in close proximity to the winged 
helix on the C terminus of the 32 kDa subunit. The change in modification suggests that 
the winged helix lies closer to the core of the 32 kDa subunit in the phosphorylated 
state, but moves away when it is bound to DNA.  
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Figure 31. View of Lys 88 in the putative binding site of DBD F in the 70 kDa subunit in 
the M80PS ribbon model. Domains are colored according to the previous scheme (Figure 
2). Lys 88 is modified in the ssDNA:RPA bound state and is not modified in the 
ssDNA:pRPA bound state. Lys 88 is in close proximity to N terminus of the 32 kDa 
subunit, which is a known site for phosphorylation.  
  
 
145 
 
 
 
  
 
146 
 
Figure 32. View of Asp 306 & Lys 379 in DBD B of the 70 kDa subunit in the M80PS 
ribbon model. Domains are colored according to the previous scheme (Figure 2). Asp 
306 and Lys 379 are modified in the ssDNA:pRPA state but are not modified in the 
ssDNA:RPA state.  
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Figure 33. View of Asp 307 & Lys 410 in DBD B of the 70 kDa subunit in the M80PS 
ribbon model. Domains are acolored according to the previous scheme (Figure 2). Both 
Asp 307 and Lys 410 are modified in native RPA and ssDNA:RPA, but are not modified in 
pRPA or ssDNA:pRPA, suggesting that this portion of DBD B becomes less exposed when 
phosphorylated.  
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modified in ssDNA:pRPA (Figures 28 & 29). In the 32 kDa subunit, again 1 amino acid, 
glutamate 70, was not modified in pRPA and was modified in ssDNA:pRPA (Figure 30). In 
the 70 kDa subunit, 2 amino acids showed differences in modification. Lysine 88 was 
modified in pRPA and was not modified in ssDNA:pRPA (Figure 31). Aspartate 306 was 
not modified in pRPA and was modified in ssDNA:pRPA (Figure 32). 
RPA vs pRPA 
When comparing RPA with pRPA (Table 10), there was no difference in the 8 
surface accessibly modified amino acids within the 14 kDa subunit (Table 10). Of the 12 
amino acid targets in the 32 kDa subunit, glutamate 70 was modified in RPA, but was 
not modified in pRPA (Figure 30). In the 70 kDa subunit, 2 amino acids, aspartate 307 
and lysine 410, were modified in RPA, but were not modified in pRPA (Figure 33).  
ssDNA:RPA vs ssDNA:pRPA  
Lastly, native RPA covalently crosslinked to ssDNA was compared to pRPA 
covalently crosslinked to ssDNA (Table 11). Aspartate 103, in the 32 kDa subunit was not 
modified in ssDNA:RPA, but was modified in ssDNA:pRPA (Figure 34). In the 70 kDa 
subunit, 6 amino acids reacted differently in the native and phosphorylated forms. 
Lysine 263 was not modified in ssDNA:RPA and was modified in ssDNA:pRPA (Figure 35), 
and lysine 410 was modified in ssDNA:RPA and not modified in ssDNA:pRPA (Figure 33). 
Lysine 273 (Figure 35), aspartate 307 (Figure 32), and lysine 379 (Figure 32) were  
 
 
151 
 
Figure 34. View of Asp 103 in the putative binding site of the 32 kDa subunit in the 
M80PS ribbon model. Domains are colored according to the previous scheme (Figure 2). 
Asp 103 is not modified in the ssDNA:RPA state but is modified in the ssDNA:pRPA state. 
As this residue lies in the putative binding site of DBD D, it suggests that all or a portion 
of the binding site is unoccupied by ssDNA in the phosphorylated state.  
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Figure 35. View of Lys 263 in the putative binding site of DBD A and Lys 273 in the linker 
region between DBD A and DBD B of 70 kDa subunit in the M80PS ribbon model. 
Domains are colored according to the previous scheme (Figure 2). Both Lys 263 and Lys 
273 are exposed in native RPA and pRPA, but are blocked by ssDNA in the bound states.  
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modified in ssDNA:pRPA and were not modified in ssDNA:RPA. Finally, lysine 88 (Figure 
31) was not modified in ssDNA:pRPA, but was modified in ssDNA:RPA. 
Discussion 
RPA vs ssDNA:RPA  
The 14 kDa subunit had 2 amino acids, aspartate 22 and lysine 49, which were 
modified in the RPA but were not modified in ssDNA:RPA. These amino acids lie in a 
groove on DBD E. This feature is common to OB fold domains9 and is very frequently an 
oligonucleotide/polysaccharide binding region. When in its native state, aspartate 22 
and lysine 49 are surface accessible and thus available for modification. When the 14 
kDa subunit binds to ssDNA, aspartate 22 and lysine 49 become blocked by the ssDNA 
adduct and are inaccessible to the chemical modifying reagents (Figures 28 & 29).  
The 32 kDa subunit had 1 amino acid with different reactivity between RPA and 
ssDNA:RPA, aspartate 103. Aspartate 103 is modified in RPA, but is not modified in 
ssDNA:RPA. Aspartate 103 is in the OB fold of DBD D and is occluded by the bound 
ssDNA adduct (Figure 34). 
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In the 70 kDa subunit, lysine 263 lies within the putative binding site of DBD 
A and lysine 273 is interposed between DBD A and B. Both residues are blocked by 
the ssDNA adduct running from DBD A to DBD B (Figure 35). Both are modified when 
in RPA but are not modified in the ssDNA:RPA suggesting that they are blocked by a 
ssDNA adduct. Aspartate 307 and lysine 379 are in DBD B, but lie outside the binding 
groove of the DBD. Both are modified in the RPA and are not modified in the 
ssDNA:RPA. Lysine 379, like lysine 273, lies between DBD A and DBD B and is blocked by 
the ssDNA strand running from DBD A to DBD B (Figure 32). Aspartate 307, however is 
outside the direct pathway of the ssDNA and would require a local variation in 
conformation to block the accessibility of this residue from covalent chemical 
modification (Figure 32). Lysine 88 is within DBD F of the 70 kDa subunit and represents 
a conformational change to go from exposed and accessible within RPA to buried and 
unreactive within ssDNA:RPA (Figure 31). 
pRPA vs ssDNA:pRPA 
Aspartate 22 and lysine 49, in the 14 kDa subunit were modified in the pRPA, and 
appear to be similarly blocked by a DNA adduct in ssDNA:pRPA (Figures 28 & 29).  
Glutamate 70 in the 32 kDa subunit was not modified in the pRPA and was 
modified in ssDNA:pRPA. This suggests that the 32 kDa subunit is more compact in the 
pRPA but opens as it becomes bound to ssDNA (Figure 30). 
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 Lysine 88, in the 70 kDa subunit was modified in pRPA and not modified in the 
ssDNA:pRPA. Again, this suggests a local conformational change that provides 
accessibility to the modified amino acid within pRPA but limits accessibility within 
ssDNA:pRPA (Figure 31). Aspartate 307 was not modified in pRPA and was modified in 
ssDNA:pRPA (Figure 32). This data again represents local changes to the conformation 
as the accessibility of each amino acid target changes allowing the reaction to occur in 
the modified state. 
Native RPA vs pRPA 
Overall, there was significant agreement of the reactivities of probed amino 
acids between all subunits of RPA and pRPA, with only minor changes between 32 and 
70 kDa subunits. In the 32 kDa subunit, glutamate 70 was modified in RPA, but was not 
modified in pRPA (Figure 30). This suggests a difference in accessibility of glutamate 70, 
with it being accessible and thus modified in RPA, but being inaccessible in the 
phosphorylated state.  
For the 70 kDa subunit, there were 2 amino acids, aspartate 307 and lysine 410, 
that were modified in RPA, but were not modified in pRPA (Figure 33). Both amino acids 
are within DBD B and are 12.6 Angstroms apart, and again, this suggests local 
rearrangement, blocking accessibility of the chemical modifying reagents in the 
phosphorylated state.  
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ssDNA:RPA vs ssDNA:pRPA 
Aspartate 103, in the 32 kDa subunit was not modified in ssDNA:RPA, but was 
modified in ssDNA:pRPA (Figure 34). Aspartate 103 is part of the β barrel of DBD D and 
extends outward from the protein in the M80PS model. This residue is most likely 
blocked by the N terminus of the 32 kDa subunit in ssDNA:RPA. Consistent with 
increased reactivity in the phosphorylated adduct, the N terminus of the 32 kDa subunit 
straightens and extends outward and would allow modification in the phosphorylated 
state48.  
In the 70 kDa subunit, there were 6 amino acids with different reactivities 
between ssDNA:RPA and ssDNA:pRPA, (D 307, K 88, K 263, K 273, K 379, & K 410). Lysine 
88 and lysine 263 were not modified in ssDNA:RPA but were modified in ssDNA:pRPA. 
Aspartate 307, lysine 273, lysine, 379, and lysine 410 were modified in ssDNA:RPA and 
were not modified in ssDNA:pRPA. All of these residues, with the exception of K 88, are 
in DBDs A & B. It suggests that local conformational changes occur in the high affinity 
binding sites of DBDs A & B which alter the conformation of the binding pocket between 
ssDNA:RPA and ssDNA:pRPA. As DBDs A & B not only bind ssDNA, but have also been 
shown to have interaction with some of RPA’s protein binding partners, the change 
between native and phosphorylated states again suggests that this rearrangement could 
influence which of those proteins make a good binding partner for each of the 2 RPA 
states. It should be noted that phosphorylation may change electrostatic interactions for 
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all amino within the phosphylated species and thus affect the ability of each amino acid 
to be modified. 
 Kinetic Evaluation for MRAN analyses of Replication Protein A 
To refine the data collected from the chemical modification reactivity analyses, 
reaction kinetics for each amino acid were evaluated. This provided greater resolution 
to the gross assessment of the chemical modification reactivities of the amino acids 
queried in this study (Tables 4 & 7). This data was primarily used to examine the 
placement of DBDs A & B on the trimerization core. The data suggests that DBDs A & B 
are docked on the trimerization core of native RPA, as shown in the M80PS model. 
Aspartate 45 and lysine 104 in the 14 kDa subunit are both part of DBD E and lie 
proximal to DBD B of the 70 kDa subunit. Both residues were scored unreactive and 
therefore not exposed in the native RPA state, suggesting that the positioning of DBD B 
on the trimerization core in the M80PS model is accurate. Additionally, lysine 183, which 
is on DBD A of the 70 kDa subunit and lies in proximity to DBD E of the 14 kDa subunit, 
was also scored unreactive and supports the placement of DBD A on the trimerization 
core. However, when RPA is bound to ssDNA, aspartate 45 and lysine 104 of the 14 kDa 
subunit, as well as, lysine 183 of DBD A are scored reactive. This suggests that DBDs A & 
B detach from the trimerization core or at least undergo substantial changes in their 
docking location when bound to ssDNA. The reactive scores for aspartate 22 and lysine 
49 of the 14 kDa subunit support this contention. Both D 22 and K 49 lie within the 
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putative binding site of DBD E and were scored reactive in the native state, but become 
unreactive and presumably inaccessible when the 14 kDa subunit of RPA is bound to 
ssDNA (Figures 28 & 29). Also, photo crosslinking data between ssDNA and RPA show 
the reaction between DBD E and ssDNA (Table 3). For this to occur, DBDs A & B must 
detach or move from DBD E to allow the access of ssDNA to the OB fold of DBD E. 
The orientation and placement of DBDs A & B when RPA is phosphorylated or 
phosphorylated and bound to ssDNA was also of interest. It has been suggested that 
RPA undergoes a structural change when it is phosphorylated. However, the extent of 
change, and how that change mimics or differs from unphosphorylated RPA is not 
understood. Reaction data for all amino acids that lie within subunit interfaces between 
DBDs A & B and the RPA trimerization core were the same as compared to their 
unphosphorylated RPA counterparts. This implies that DBDs A & B are similarly docked 
to the trimerization core of RPA when the molecule is phosphorylated and detach from 
the trimerization core when phosphorylated and bound to ssDNA.  
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Table 12. Scoring rubric for kinetic evaluation of chemical reactivities of amino acids. 
Each mass spectrum peak corresponding to an observed peptide was evaluated by this 
rubric dependent upon the indicated number of modifications (table on following 2 
pages). 
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Sites are classified as 
 U: Unreactive (no shift)                   
 R: reactive (shifted and unshifted (parent) peptides 
present)                    
 V: very reactive (all peptides are shifted)                    
                    
number of modification the peptide is shifted by: 
 
                
  0   1   2   3   4 
one site per peptide                   
                    
U                   
R                   
V                   
                    
two sites per peptide                   
U2                   
UR                   
UV                   
R2                   
RV                   
V2                   
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Three sites per 
peptide                   
U3                   
U2R                   
U2V                   
R2U                   
VRU                   
V2U                   
R3                   
R2V                   
V2R                   
V3                   
                    
Four  Sites per 
peptide                   
U4                   
U3R                   
U3V                   
R2U2                   
VRU2                   
V2U2                   
R3U                   
R2VU                   
V2RU                   
V3U                   
R4                   
R3V                   
V2R2                   
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Another area of interest within RPA is DBD F on the N terminus of the 70 kDa 
subunit. The kinetic scoring data was used to evaluate whether there was a change in 
reactivitiy of residues in the interfaces between DBD F and DBD D of the 32 and DBD E 
of the 14 kDa subunits, respectively. For all amino acids scored within interacting sites, 
there was no change in reactivities between native and phosphorylated, native and 
ssDNA bound, phosphorylated and phosphorylated ssDNA bound, or native ssDNA 
bound and phosphorylated ssDNA bound states. This suggests that DBD F does not 
reorient under any of the binding states examined. Data from the covalent photo 
crosslinking of RPA and pRPA indicates that DBD F is bound to ssDNA in the native state, 
but not in the phosphorylated state. MRAN data suggests that this region does not 
undergo local conformational change with phosphorylation for the amino acids studied 
here, or perhaps that DBD F presents a different electrostatic environment when 
phosphorylated that is not conducive to crosslinking of ssDNA, though it is crosslinked in 
the unphosphorylated state.  
Evaluation of Modification Reactivity with proposed structures 
The chemical modification reactivity analysis data was then used to evaluate 
structures of pieces of RPA and the structure proposed by the Alter laboratory (1JMC, 
1L1O, 1FGU, 1DPU, 3KDF, 1EWI, 4R4C, M80PS, and 4GNX) to determine their relevance 
to solution state RPA whose structure has been probed in this thesis dissertation (Tables 
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5 & 6). As previously noted, the structures evaluated were proposed based on x-ray 
crystallographic, NMR, and simulated annealing data for the protein. 
 For the 14 kDa subunit, crystallographically derived models 3KDF and 1L1O were 
consistent the in vitro data reported here for all chemically modified amino acids in this 
study (Tables 5 & 6). The M80PS model proposed by our lab for the apo structure of RPA 
did not match the chemical modification results reported here for the EDC glycine 
methyl ester or sulfo-NHS acetate reactions well, with only aspartate 3 in the EDC 
reaction and lysine 33 in the sulfo-NHS acetate reaction having surface exposures that 
corresponded to experimental results (Tables 5 & 6). As M80PS is a model built by 
additively placing crystal structures reported for pieces of RPA8 onto the reported 
crystal structure of the trimerization core of RPA, the solvent accessible surface areas of 
amino acids within subunit-subunit and domain-domain interfaces, as well as flexible 
linker regions for each piece were often one of several simulated annealing structures, 
that appeared to correspond best with experimental data. The majority of the 
discrepancies between the M80PS model and the data reported here are for surface 
exposures for amino acids that are in regions between unstructured sequence and 
domain interfaces. These unstructured sequences in M80PS are 1 of 15 interconvertible 
conformations reported for the inherently unstructured regions and likely differ from 
the structure in solution and would account for the differences between the M80PS 
structure and the experimental results reported here. 
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 For the 32 kDa subunit, M80PS, and the crystallographically derived 1L1O and 
1DPU structures, all are consistent with the experimental results for the EDC reaction of 
RPA and pRPA as well, with the exception of glutamate 70 which is buried within the 
M80PS model but is reactive within the experimental results (Table 5). Glu 70 faces the 
winged-helix on the C terminus of the 32 kDa subunit. It is believed that the winged-
helix is loosely tethered to DBD D. Its positioning on DBD D, in the M80PS model, is 
again 1 of several possible interaction sites. Results from the sulfo-NHS acetate reaction 
for the 1L1O and 1DPU reported structures matched experimental results (Table 6). 
M80PS did not match results for lysine 85 and was inconclusive for lysine 171 (Table 6). 
Lysine 85 is also blocked by a loose tether in the M80PS model, and its placement can 
vary.  
For the 70 kDa subunit, the crystallographically derived 1FGU and 1JMC 
structures matched all experimental results for the EDC reactions for both RPA and 
pRPA (Table 5). M80PS matched RPA and pRPA well, by coinciding with 11 of the 13 
amino acids probed (Table 5). The sulfo-NHS reactions of RPA and pRPA, 1FGU and 1JMC 
again matched all experimental results (Table 6). M80PS was consistent with 
experimental results matching 13 of the 15 probed amino acids (Table 6). The exception 
to these results again resides in the ssDNA:RPA and ssDNA:pRPA models. As previously 
indicated, the data suggests that DBDS A & B detach from the trimerization core and 
function independently from the core molecule. M80PS accurately reflects the structure 
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when the protein is DNA free. However, it does not accurately represent the ssDNA 
bound structure. The crystallographically derived structure, 4GNX, proposed by 
Pavletich et al. is consistent with the data reported here for the placement of DBDs A & 
B when RPA is bound to ssDNA. 
While the complete RPA heterotrimer has not been examined by x-ray 
crystallography and NMR, many truncated species have been studied. By comparing the 
predicted surface accessibility of specific amino acids within each model with direct in 
vitro experimentation, the validity of each structure was evaluated. Our data supports 
the reported structures for the models previously mentioned, with the exception of 
minor changes for native and phosphorylated RPA free of ssDNA substrate. This 
suggests that not only do these models correctly represent the portions of the protein 
that they directly studied, but taken as a whole, a picture of the complete RPA 
heterotrimer in native and phosphorylated states can be derived. The data that suggests 
DBDs A & B detaches from the trimerization core and calls into question the validity of 
these structures for the molecule when bound to ssDNA substrate. It suggests that a 
reevaluation of the structures are necessary when describing the molecule as it interacts 
with ssDNA.  
As a means of understanding the reported structures for RPA, the structural and 
functional interactions described in the literature were compared to our reported 
experimental results. In comparing NMR data by Brosey et al.19 from a 2009 paper, 
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there were several discrepancies between the reported and postulated structural 
interactions of RPA and ssDNA with our experimental data. Brosey et al. cited no 
reactivity of the C terminal region of the 32 kDa subunit with a ssDNA 30mer. Our 
experimental data from the covalent photo crosslinking of RPA and pRPA directly 
contradicts this argument. The C terminus extends from methionine 200 through the 
terminal glutamate 270. We report multiple peptides covalently crosslinked with ssDNA 
in this portion of the protein. Peptides bound were as follows: (RPA 218-231, 232-243, & 
257-270 and pRPA peptides 235-248, & 257-270, data not shown). This suggests that the 
C terminus of the 32 kDa subunit is juxtaposed away from the trimerization core when 
bound to ssDNA and is available for photo crosslinking to RPA bound ssDNA. Further, 
Brosey et al. showed no interaction of the N terminus of the 70 kDa subunit (residues 1-
114) with ssDNA. Again, our experimental data directly contradicts this result. In RPA 
peptides 88-96 & 103-122 (data not shown) are directly covalently crosslinked with 
ssDNA. Brosey et al. additionally suggested that RPA 70 DBDs A & B are associated with 
the trimerization core when bound to ssDNA. Again, our experimental data contradicts 
this result. The direct covalent crosslinking of DBD E of the 14 kDa subunit as well as the 
reactivity data for aspartate 45 and lysine 104 in the 14 kDa subunit and lysine 183 in 
DBD A can only result when DBDs A & B are separated from the trimerization core and 
allow access or the ssDNA with this region.  
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In a 2012 paper Pavletich et al.71 used x-ray crystallography to examine a 
truncated structure of RPA from U. maydis, (4GNX). The N terminus of the 70 kDa 
subunit and the C terminus of the 32 kDa subunit were not present. The justification for 
the truncated species is lack of direct experimental evidence for interaction with ssDNA. 
They further present data that the linker region between DBDs B & C is buried when the 
protein is bound to ssDNA. Our data for RPA and pRPA contradicts and coincides with 
differing portions of this structure. In RPA, peptides corresponding to N terminus of the 
70 kDa subunit and the C terminus of the 32 kDa subunit as well as the B-C linker region 
of the 70 kDa subunit were covalently chemically modified and covalently photo 
crosslinked with ssDNA. The unstructured region between DBD B and DBD C, peptides 
415-422 & 413-431 (data no shown) in RPA and 413-431 & 416-422 (data not shown) in 
pRPA, were covalently modified by the EDC glycine methyl ester reaction. The 
modification of the peptides within this region can only occur if the portion of the 
protein between DBD B and DBD C is solvent accessible. In addition to the truncations 
mentioned in the previous paragraph, (the N terminus of the 70 kDa subunit and the C 
terminus of the 32 kDa subunit), were also targets for direct covalent ssDNA binding. 
This calls into question the justification of the truncated species used for this study. 
However, 4GNX does present DBDs A & B as disjoined from the trimerization core when 
bound to ssDNA. The loose tether to the trimerization core presented in 4GNX agrees 
with our experimental results and allows for binding of the 14 kDa subunit with ssDNA. 
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It should be noted that the reported structure by Pavletich et al.71 is for the protein in 
crystal state and may not accurately describe the structure of the protein in a solution 
state. It is the inherent difference between crystal and solution states that could 
account for the discrepancies between the data presented by Pavletich et al. and the 
data reported here.  
A 2015 paper, by Brosey et al.38 measured the rotational independence or 
interdependence of DBD A and DBD B in the absence of ssDNA or in the presence of a 
ssDNA 10mer. This paper cited great independence between the unbound DBDs, but 
noted an interdependent rotation when bound to ssDNA. The latter agrees with all 
reported structures of DBDs A & B bound to ssDNA. Brosey et al. also measured the 
rotational independence of DBD F to the rotationally dependent DBDs A & B in the 
presence of the ssDNA ligand. They noted completely independent mobility between 
domains A & B to domain F in the presence of ssDNA substrate. Here, they again used a 
ssDNA 10mer as a substrate. Our experimental results, with a ssDNA 30mer, show direct 
covalent photo crosslinking between DBD F and ssDNA. We argue that the ssDNA 10mer 
is not large enough to bind A & B and extend to F. It is the insufficient length of this 
substrate that allows for the free rotation of the N terminus. 
A 2005 paper by Shell et al.79 reported the protection of lysines in the DNA 
binding sites of DBDs A, B, C, and D from sulfo-NHS-biotin modification. Shell et al. 
reported protection of lysines 183, 259, 263, 343, 489, 577, and 588 in the 70 kDa 
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subunit. Our data agrees with all but 2 of these residues. We did not see protection of 
lysines 183 and 259 in DBD A. We postulate that it is the difference in the physical 
properties of their reagent in relation to ours that did not allow the modification of 
these residues. Sulfo-NHS biotin places a large (MW 244.31 of 13.1 Angstrom length) 
biotin on the primary amine in a lysine. This reagent, due to its size, could make it a poor 
reagent for reaction with these residues. The acetyl group placed on the primary amine 
in lysines in the sulfo-NHS acetate reaction is significantly smaller (MW 43.05) and 
subsequently more accessible to smaller ligand binding sites. Further, Shell et al. did not 
see protection of any lysines in DBD D of the 32 kDa subunit nor DBD E of the 14 kDa 
subunit. We report protection of lysine 49 (Figure 28) in the 14 kDa subunit when it is 
bound to ssDNA. Further, because we employed a second modifying reagent, we also 
report protection of aspartates 22 (Figure 29) and 95 (Figure 36) in the 14 kDa subunit, 
as well as aspartates 95, 96, and 103 (Figure 37) in the 32 kDa subunit, consistent with 
our placement of the ssDNA 30mer in the RPA structure.  
The compilation of multiple reported and postulated structures when compared 
to direct experimental evidence demonstrates that the structure of Replication Protein 
A is still not completely understood. As various laboratories report truncated structure, 
and postulate the whole structure of the protein, here we present data for the complete 
protein in solution that provides a more insightful approach to structure determination. 
When this data is taken in conjunction with the previously reported and postulated  
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Figure 36. View of Asp 95 in the 14 kDa subunit in the M80PS ribbon model. The model 
is colored according to the previous scheme (Figure 2). Asp 95 is blocked by a ssDNA 
adduct in the ssDNA bound state, but is modified in the ssDNA free state. 
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Figure 37. View of Asp 95, 96, and 103 in the 32 kDa subunit in the M80PS ribbon model. 
The model is colored according to the previous scheme (Figure 2). Asp 95, 96 and 103 
are blocked by a ssDNA adduct in the bound state, but are modified in the ssDNA free 
state. 
  
 
175 
 
 
  
 
176 
 
structures, a higher resolution understanding of RPA in native, phosphorylated, ssDNA 
bound, and phosphorylated ssDNA bound states is achieved. It is through this analysis 
that a full model of RPA in its various reaction states can be determined. The 
rearrangement and adjustment of models to correspond with experimental data 
obtained from MRAN, will give a more precise depiction of the complete RPA molecule.  
 
Through the use of covalent photo crosslinking, in conjunction with mass 
spectral analysis, we have mapped the sites of covalent chemical bonds between 
specific amino acids and poly dT30 in all 3 subunits of RPA in both its native and 
phosphorylated states. We have demonstrated that the 14 kDa subunit has direct 
interaction with ssDNA in both native and phosphorylated states. Further, we have 
demonstrated that minor structural changes occur between native and phosphorylated 
species in all 3 subunits and provide different target amino acids that are able to 
covalently bind with ssDNA under different experimental conditions. Further, we have 
detected changes at the local level in all DBDs and subunits between, native, 
phosphorylated, ssDNA bound, and phosphorylated ssDNA bound states. We have 
demonstrated that the changes in phosphorylation state do not affect global structure 
of the molecule, but does alter the ssDNA binding interactions between native and 
phosphorylated species. We have noted that DBDs A & B must detach from the 
trimerization core to correspond with ssDNA covalent binding and chemical 
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modification reactivity data for native and phosphorylated RPA. This is a global change 
for the orientation of DBDs A & B, when the protein is bound to ssDNA. This suggests 
that RPA is a highly flexible and dynamic molecule that undergoes significant 
rearrangement between apo and bound states. More so, the data reported here 
supports the structure (M80PS) proposed by our lab8 for RPA in its unphosphorylated 
and ssDNA free state.  
Probing the structure of RPA with chemical modifying reagents that target 
different amino acids than those used in this study will further refine the physical 
understanding of the molecule. Investigation into the local changes, and more 
specifically, how these changes affect protein-protein interactions and protein-DNA 
interactions will broaden the understanding of the role of the individual subunits and 
DBDs of RPA. RPA is a complex and modular protein, but with continued study and 
analysis, the full scope of the conformations it adopts to achieve differing functions 
within the cell will be more fully understood. 
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Structural Basis for RPA’s Biological Functions 
The roles of RPA within the cell have proven to be both many and essential. RPA 
is the highest affinity single strand DNA binding protein within the cell58, but also serves 
the role of a key player involved in DNA maintenance and metabolism49,80,81. To achieve 
this, RPA not only binds ssDNA45, dsDNA82, and RNA83, but interacts with proteins that 
cover the scope of cellular functionality49. RPA, in conjunction with its protein binding 
partners, helps to regulate replication, recombination, damage repair, as well as cell 
cycle and DNA check point signaling45,47,50,84. Our and other’s experimental results show 
that RPA is a dynamic protein and highly modular. RPA adapts its conformation in 
response to its DNA binding and phosphorylation interactions state71. It is its inherent 
modularity that allows RPA to function distinctly depending upon which task it is 
involved in.  
Cell Cycle 
 The modular nature, as well as the differing conformations that RPA adopts 
under each reactive state brings forth intriguing questions as to what role RPA serves 
throughout the cell cycle. Immunolocalization of RPA shows it in the nucleus in 
replication foci prior to replication through S phase49. More so, punctate stains of RPA 
show its persistence in the nucleus through all cell cycles53. RPA is phosphorylated at the 
onset of S phase and remains phosphorylated through early mitosis47, but becomes 
dephosphorylated in the latter stages of mitosis49. One primary function is for RPA to 
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bind to ssDNA at the replication fork85. In taking into account our reported data that 
DBDs A & B, dissociate from the trimerization core upon ssDNA binding (Ch3. In this 
dissetation), this suggests that the many of the protein binding partners of RPA that 
bind to multiple subunits/domains of RPA simultaneously would not make favorable 
substrates for binding to this extended state during replication. This conjecture is 
supported by the fact that many of these binding partners are essential components in 
the DNA damage repair pathways. Adopting a conformation that dissuades binding of 
these proteins, would aid replication by lowering affinity of protein binding partners 
involved in other processes in the cell. As RPA is phosphorylated during S phase, this too 
changes local conformation of the protein in DNA binding sites, as well as in sites of 
subunit and domain interaction (Ch. 4 in this dissertation). Local rearrangement of the 
protein at the sites of DNA binding or within inter subunit and inter domain regions 
would allow function specific interaction within the replication foci and would aid 
recruitment of proteins involved in DNA metabolism. It has further been hypothesized 
that phosphorylation of RPA functions in cellular signaling. The rearrangement of DBDs 
as well as the sites of inter subunit and inter domain interaction would support this 
hypothesis by changing affinity of DBDs to ssDNA as well as change affinity for specific 
protein binding ligands under each reactive state. When RPA detaches from the 
replication foci, it returns to its compact, dephosphorylated state. Returning to this 
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conformation would essentially reset RPA as a substrate and allow it to bind to damaged 
DNA or protein partners that function in other pathways within the cell.  
MRAN data for the N terminus of the 70 kDa subunit, a site for protein-protein 
interaction, suggests that the domain functions independently of DNA binding or 
phosphorylation state under the conditions tried here (Ch. 4 in this thesis). It would 
remain a susceptible site for protein-protein reactions with little influence in its 
reactivity based on the conformational changes reported here.  
DNA Damage 
As noted earlier, RPA is hyperphosphorylated during DNA damage67. Specifically, 
the N terminus of the 32 kDa subunit as well as portions of the 70 kDa subunit are 
phosphorylated53,48. However, phosphorylation has not been shown to be essential for 
RPA’s functions in nucleotide excision repair and base excision repair84,6. Again, it seems 
that the conformation of RPA between the DNA free-state and bound-state influences 
its function during DNA damage. When in a DNA free-state, both RPA and pRPA are in a 
compact conformation with all DBDs from the 70, 32, and 14 kDa subunits associated 
around the trimerization core of the protein. The proximity of DBDs A & B to DBDs C, D, 
and E allow for interactions with protein binding partners that span multiple subunits. 
The nucleotide excision repair protein Xeroderma pigmentosum A (XPA) interacts with 
both the 70 and 32 kDa subunits of RPA simutaneously44. The close association of the 3 
subunits of RPA, when in the DNA free-state, present favorable binding sites for this 
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interaction. As RPA binds to ssDNA at a site of DNA damage, the XPA ligand interaction 
would change. It would seem likely that XPA would detach from RPA when it is in an 
extended state with DBDs A & B detached from the 32 kDa subunit. By freeing RPA from 
the XPA ligand, RPA would then be able to recruit other known protein interacting 
partners like, Xeroderma pigmentosum F, (XPF)86, and ERCCI87, that are also involved in 
nucleotide excision repair. Additionally, both RAD 52 (which is essential for homologous 
recombination)68 and uracil DNA glycosylase (which is essential for base excision 
repair)88 have been shown to bind to the same interacting site as XPA on the 32 kDa 
subunit. Making XPA a less favorable substrate, would decrease competition for these 
proteins and allow RPA to assume a different function within the cell.   
Another example of how this modularity influences function, is the interaction of RPA 
with DNA protein kinase (DNA-PK). DNA-PK aids phosphorylation of RPA6 ,forms a 
complex with the 70 kDa subunit6 and is able to identify and bind to sites of DNA 
damage as well as inhibit DNA polymerase alpha primase activity56. DBDs A & B of the 
70 kDa subunit interact with DNA polymerase alpha primase in the absence of 
phosphorylation and DNA damage73. Phosphorylation of RPA by DNA protein kinase, 
does not significantly change the structure of the 70 kDa subunit but does make local 
changes that influence the amino acids that bind ssDNA within DBDs A & B (Ch. 4 in this 
thesis). As it is believed that this is also the site of DNA polymerase alpha primase 
binding, local changes to structure in the binding sites of DBDs A & B would influence its 
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interaction with DNA polymerase alpha primase. This could slow or hinder replication 
and allow repair machinery to function.  
Nontraditional Function 
Another aspect of RPA is its ability to bind to non b-form DNA. More specifically, 
RPA has been shown to bind to triplex and quadraplex DNA89,90. The local 
conformational rearrangement of DBDs and inter domain and inter subunit reaction 
sites could potentially aid this function. The ability of the 14 kDa subunit of RPA to bind 
DNA independently of DBDs A, B, C, and D (Ch. 3 in this thesis), suggest that RPA has the 
ability to bind to DNA in an alternative mode that does not follow its previously 
reported action. It is possible that the interaction of the 14 kDa subunit is required for 
binding the nontraditional DNA substrates.  
Closing Remarks 
The primary function of RPA, binding ssDNA, has the most drastic effect on the 
structure of the protein and subsequently dictates its functions and interactions within 
the cell. The change from the compact ssDNA free molecule to an extended ssDNA 
bound protein not only influences the global structure of RPA, but changes the proteins 
ligand binding sites and inherently its function within the cell. Phosphorylation of the 
protein serves not only as a cellular signal, but allows slight adjustments to protein and 
DNA interacting sites that in turn influence its affinity for specific ligands. It is the 
adaptive plasticity of the protein that allows it to be involved in so many cellular 
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processes, and it is this modularity that continues to provide newly discovered and 
vitally important functions within the cell.  
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